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Statement of Problem: In the field of developmental psychopathology, there has been a historical debate
colloquially referred to as “nature versus nurture” in the continued pursuit of understanding the genetic
and environmental origins of mental illness. The emergent field of behavioral epigenetics has posited that
the underlying dichotomy and conceptual separation between gene and environment influences itself is
false. Epigenetic processes show that environmental influences act on genes mechanistically as
environmental inputs biologically influence the expression of key genes in vital systems. In translating
technological advances in epigenetics from the biomedical world, developmental psychopathologists
have largely contextualized psychological phenotypes within the same biomedical disease model.
However, psychological phenotypes are not automatically amenable to the same methodological
framework, as they are uniquely complex in their classification and measurement and are best
understood to be calibrated in early life during crucial periods of development. Methods and Procedures:
Therefore, the central aim of this thesis was to apply epigenetic theory, methodology, and technology to
clinically relevant psychological phenotypes in methodologically novel ways that take into account
phenotypic complexity and developmental context. Using a longitudinal design from the Avon
Longitudinal Study of Parents and Children (ALSPAC), this thesis explored the epigenetic underpinnings
(i.e. DNA methylation) of risk and resilience for internalizing and externalizing disorders during sensitive
periods of development. Results: Study 1, published in Development and Psychopathology in 2017, used a
candidate gene approach examining epigenetic changes in the oxytocin receptor gene (OXTR) to study
resilience to prenatal stress. Results showed that children who were resilient in the conduct problem
domain only had differential DNA methylation profiles at birth than those who were not resilient. Study 2
used an epigenome-wide approach to explore potential novel epigenetic correlates of depression
trajectories in adolescence with follow-up bioinformatic analyses. Results did not show any fetal
programming effects when assessing DNA methylation at birth, but several novel genes were identified
when DNA methylation was measured in adolescence. Conclusion: Because these epigenetic changes
are heritable and potentially reversible, insights from epigenetic research have profound implications in
the classification, identification, and treatment of mental illness.
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ABSTRACT
LONGITUDINAL ANALYSES OF EPIGENTIC CORRELATES OF
EXTERNALIZING AND INTERNALIZING DISORDERS
Izabela Milaniak
Sara R. Jaffee
Statement of Problem: In the field of developmental psychopathology, there has been a
historical debate colloquially referred to as “nature versus nurture” in the continued
pursuit of understanding the genetic and environmental origins of mental illness. The
emergent field of behavioral epigenetics has posited that the underlying dichotomy and
conceptual separation between gene and environment influences itself is false. Epigenetic
processes show that environmental influences act on genes mechanistically as
environmental inputs biologically influence the expression of key genes in vital systems.
In translating technological advances in epigenetics from the biomedical world,
developmental psychopathologists have largely contextualized psychological phenotypes
within the same biomedical disease model. However, psychological phenotypes are not
automatically amenable to the same methodological framework, as they are uniquely
complex in their classification and measurement and are best understood to be calibrated
in early life during crucial periods of development. Methods and Procedures:
Therefore, the central aim of this thesis was to apply epigenetic theory, methodology, and
technology to clinically relevant psychological phenotypes in methodologically novel
ways that take into account phenotypic complexity and developmental context. Using a
longitudinal design from the Avon Longitudinal Study of Parents and Children
(ALSPAC), this thesis explored the epigenetic underpinnings (i.e. DNA methylation) of
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risk and resilience for internalizing and externalizing disorders during sensitive periods of
development. Results: Study 1, published in Development and Psychopathology in 2017,
used a candidate gene approach examining epigenetic changes in the oxytocin receptor
gene (OXTR) to study resilience to prenatal stress. Results showed that children who
were resilient in the conduct problem domain only had differential DNA methylation
profiles at birth than those who were not resilient. Study 2 used an epigenome-wide
approach to explore potential novel epigenetic correlates of depression trajectories in
adolescence with follow-up bioinformatic analyses. Results did not show any fetal
programming effects when assessing DNA methylation at birth, but several novel genes
were identified when DNA methylation was measured in adolescence. Conclusion:
Because these epigenetic changes are heritable and potentially reversible, insights from
epigenetic research have profound implications in the classification, identification, and
treatment of mental illness.
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INTRODUCTION
In the field of developmental psychopathology, there has been a historical debate
colloquially referred to as “nature versus nurture” in the continued pursuit of
understanding the genetic and environmental origins of mental illness. A strong research
base of twin and adoption studies supports the heritability of psychological disorders (e.g.
Larsson et al., 2014; Lohoff, 2010; Verhulst et al., 2015). At the same time, a wealth of
research supports the strong impact of environment (i.e. trauma, maltreatment, poverty)
on the development of psychopathology, especially in early sensitive periods of
development (e.g. Carr et al., 2013; McCrory et al., 2012; McLaughlin & Lambert, 2017;
Reiss, 2013). In the past two decades, the “nature versus nurture” debate has been
effectively resolved with the understanding that genes and environment both play vital
roles through dynamic interplay with one another. Gene-environment interaction research
has shown a moderation relationship between genetic influences and the environment
where the presence of a particular genotype influences the impact of an environmental
stressor and vice versa (e.g. Brown & Harris, 2008; Koenen et al., 2008; Lau et al., 2007;
Nugent et al., 2011). However, the interaction of genes and environmental exposures in
these paradigms are purely statistical and still operate under the conceptualization that
they are distinct and separate processes. The emergent field of behavioral epigenetics has
posited that the underlying dichotomy and conceptual separation between gene and
environment influences itself is false. Epigenetic processes show that environmental
influences act on genes mechanistically as environmental inputs biologically influence
the expression of key genes in vital systems such as the stress response and immune
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systems. Thus, the theory underpinning behavioral epigenetics suggests that epigenetic
mechanisms serve as the mediator of the relationship between life experiences and
psychopathology. Because these epigenetic changes are heritable and potentially
reversible, insights from epigenetic research have profound implications in the
classification, identification, and treatment of mental illness.
Research on epigenetic changes as potential mechanistic explanations for disease
began in the biomedical world, particularly in cancer research. In translating
technological advances in epigenetics from the biomedical world, developmental
psychopathologists have largely contextualized psychological phenotypes within the
same biomedical disease model. However, psychological phenotypes are not
automatically amenable to the same methodologic framework, as they are uniquely
complex in their classification and measurement and are best understood to be calibrated
in early life during crucial periods of development. Therefore, the central aim of this
thesis was to apply epigenetic theory, methodology, and technology to clinically relevant
psychological phenotypes in methodologically novel ways that take into account
phenotypic complexity and developmental context. Using a longitudinal design from the
Avon Longitudinal Study of Parents and Children (ALSPAC), this thesis explored the
epigenetic underpinnings of risk and resilience for internalizing and externalizing
disorders during sensitive periods of development. Study 1, published in Development
and Psychopathology in 2017, used a candidate gene approach examining epigenetic
changes in the oxytocin receptor gene (OXTR) to study resilience to prenatal stress.
Study 2 used an epigenome-wide approach to explore potential novel epigenetic
correlates of depression trajectories in adolescence.
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CHAPTER 1: Epigenetic Molecular Mechanisms and Bioinformatic Methods
Molecular Mechanisms of Epigenetics
The term “epigenetic” means “in addition to changes in genetic sequence” and the
term “epi”-genome references the epigenetic signaling layer that sits “on top of” the
genome. There has been much debate over the definition of “epigenetic” including what
the term means conceptually and what processes it is describing. Over time, it has
evolved to a broad definition to include any process that alters gene activity without
changing the underlying DNA sequence (Weinhold, 2006).
The term epigenetics was first introduced by Conrad Waddington in the 1940s to
describe the process that allows genotypically identical cells to be phenotypically distinct
and differentiate into diverse tissue types with specified functions (Waddington, 1957).
For example, a neuron is different from a liver cell, which is different from a skin cell,
though they all originated from the same identical nucleotide sequence. During
embryogenesis, epigenetic mechanisms govern the process of cell differentiation, which
results in the permanent and stable specialization of cellular function that is then “stored”
in the transcriptional profile of every cell and maintained throughout the lifespan
(O’Donnell & Meaney, 2020). During this process, certain aspects of a cell’s genome that
are not needed for its specialized function are silenced at the level of transcription and
subsequent expression due to epigenetic signaling. In this way, epigenetic mechanisms
can be thought of as defining the bounds of cellular function for a particular cell. Today,
we now understand that in addition to maintenance of cellular identity, epigenetic
processes co-ordinate a wide range of biological processes including stress response,
immune function, and neurodevelopment (Handy et al., 2011).
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Epigenetic mechanisms regulate the process in which a DNA nucleotide sequence
is transcribed and subsequently expressed to produce a phenotype. There are several
interrelated molecular processes that fall under the epigenetic umbrella including histone
modifications and chromatin remodeling, DNA methylation, and non-coding RNAs (Kim
et al., 2008; Peschansky & Wahlestedt, 2014). The best-known epigenetic process by far
is DNA methylation, largely because it has been the easiest and least expensive to study
with existing technology. DNA methylation refers to the addition of a methyl group
(CH3) to a cytosine guanine dinucleotide (CpG) at the 5-position of the pyrimidine ring
through a covalent bond (Deaton & Bird, 2011; Klose & Bird, 2006). This process is
catalyzed by enzymes known as DNA methyltransferases (DNMTs) that transfer methyl
groups to CpG sites within a continuous stretch of DNA. The addition of a methyl group
is typically associated with reduced binding access of transcription factors to the DNA
sequence and subsequent reduction gene expression or gene “silencing”- though this is
not always the case. In the promoter regions that are upstream from a transcription site,
DNA methylation leads to gene suppression (Bird, 2002). However, in other regions such
as the gene body, DNA methylation increases transcription levels and subsequent
expression through processes that are still unknown (Maunakea et al., 2010; Shenker &
Flanagan, 2012).
DNA methylation only occurs at the cytosine-guanine dinucleotide (CpG site).
CpG sites are rare in the genome due to mutation of methylated cytosine into thymine
over evolutionary time (Saxonov et al., 2006). Therefore, CpG sites frequently cluster
together in CpG “islands” near promoter regions of genes (i.e. areas that initiate gene
transcriptions), particularly near the transcription start sites of housekeeping genes that
are necessary for basic functions of the cell (Deaton & Bird, 2011). CpG islands are
4

defined as regions with at least 500bp, a CG percentage greater than 55%, and an
observed-to-expected CpG ratio greater than 65% (Takai & Jones, 2002). CpG islands are
largely unmethylated, do not vary across individuals, and their methylation status tends to
be more stable over time. DNA methylation is more dynamic (i.e. prone to change) and
variant between individuals in regions flanking CpG islands called shores and further out
called shelves, where CpG sites are less dense (Irizarry et al., 2009; Ziller et al., 2013).
DNA methylation can be extracted from any relevant tissue. In psychological research,
peripheral tissues including saliva, buccal epithelial cells and most commonly blood are
most typically used as brain tissue availability is limited to post-mortem sampling.
DNA Methylation Bench Science
The most common method to analyze DNA methylation is through the technique
of bead-type hybridization using micro-arrays. The Illumina Infinium HumanMethylation
Beadchip has become the default array of choice for DNA methylation studies across
disciplines. The Illmunia micro-array was designed to detect levels of DNA methylation
at CpG sites through quantitative genotyping of C/T polymorphisms (Dedeurwaerder et
al., 2014). The following protocol information was obtained from the Infinum HD Assay
Methylation Protocol Guide (2015) from Illumina’s website. The Beadchip is a handsized silicone based array with 12 arrays (6 rows, 2 columns) each array representing one
participant’s DNA sample. In each individual array, there are tens of thousands of grids.
Each grid has beads that are coated with hundreds of thousands of “probes” which are
synthetic single strands of DNA fragments, also known as oligonucleotides, each with
their own specific DNA sequence that is designed to be complimentary to human
genomic DNA. Extracted single strand genomic DNA from an individual will bind to
these complimentary probes to create double stranded DNA.
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After single strand extraction, a participant’s DNA is bisulfite converted, a
process that turns all the unmethylated cytosine bases into thymine while all the
methylated cytosine bases are protected from the biological reaction and remain
unchanged. The treated DNA is then transferred to the Illumina Beadchip for processing
of DNA hybridization, where the single strand of human DNA recombines with another
single strand of synthetic DNA by complimentary nucleotide bases. The unmethylated
cytosines form single nucleotide polymorphisms that are identified by fluorescent
staining that represents the level of DNA methylation in that region. The fluorescence is
scanned using Illumina IScan and then quantified into beta values that represent the
proportion of methylation in that genomic region using a ratio of the methylated probe
fluorescent intensity (methylated signal) over the overall intensity (sum of methylated
and unmethylated signal). Each CpG site has a corresponding beta value representing a
ratio from 0 (no cytosine methylation) to 1 (complete cytosine methylation) (Bibikova et
al., 2011).
There are 28 million CpG sites in an individual’s epigenome and the Illumina
interrogates a small subset of them based on theoretical functional importance selected
with the guidance of a consortium comprised of 22 methylation researchers representing
19 institutions worldwide (Bibikova et al., 2011). Illumina is consistently evolving its
biotechnology to not only increase the coverage of the array but also to incorporate
research findings into choosing more relevant regions to target. The first edition of the
array had coverage of 27,000 CpG sites. The 450k array, which was the technology used
to generate data for this thesis, covered 485,000 CpG sites. The new EPIC array covers
850,000 CpG sites in the human epigenome. The Illumina 450k focuses on CpG islands
(covers 96% of all islands in the human epigenome), shores (92%), and shelves (86%)
6

and also other functional elements including 3´- and 5´-UTRs, gene bodies, DNAse
hypersensitive sites, miRNA promoters and other ncRNAs that also may be important
sites for changes in DNA methylation (Bibikova et al., 2011). The 450k also covers 99%
of the Reference Sequence (RefSeq) database, which is a comprehensive annotation of all
nucleotide sequences and their protein products in the human genome (Pruitt et al., 2005).
While whole-genome sequencing techniques are able to interrogate every single CpG
site, they are often resource and cost heavy (e.g. $1,000 per participant). In addition,
research has shown that the results from the Illumina arrays are correlated R2 = .95 with
results drawn from whole-genome sequencing, suggesting that the arrays are efficiently
targeting functionally important CpG sites (Bibikova et al., 2011).
Once DNA methylation has been assayed, a matrix data file is created with each
CpG site interrogated and its corresponding DNA methylation beta value. The data
undergoes pre-processing which includes various quality checks and normalization to
correct for batch effects. During the data analysis phase, any differentially methylated
CpG sites or “hits” are annotated to their respective genes. In order to examine whether
multiple hits are functionally related, the annotated genes are entered into a gene network
analysis. More details on quality checks and normalization are available in Chapter 3,
Section C. Data analysis of DNA methylation data is described further in subsequent
empirical chapters.
Most early DNA methylation studies in developmental psychopathology used a
candidate gene approach where specific genes were chosen a priori due to known
biological, physiological, or functional relevance based on theoretical importance and
empirical evidence from genetic studies. A candidate gene approach is useful because it
allows for researchers to understand the functional elements of epigenetic changes in a
7

larger system. The design allows a drill down approach where all parts of the biological
cascade including DNA methylation, access to transcription factors, and gene expression
can be studied in unison. However, a candidate gene approach is limiting in that it is only
able to explore already identified and well-known genes. A complimentary approach is
the epigenome-wide association study (EWAS), a “hypothesis-free” approach, where an
individual’s whole epigenome is interrogated and CpG sites or regions that are
differentially methylated across individuals or “hits” are annotated to nearby genes. This
approach allows for the discovery of potentially novel biological correlates and can
contribute to a more comprehensive and holistic understanding of etiology of
psychopathology.
CHAPTER 2: Application of Epigenetics to Etiology of Psychopathology
Role of Epigenetics in Risk for Psychopathology
Epigenetic mechanisms are normative background processes that are essential to
many organism functions. Researchers across disciplines are studying when and how
these processes are altered to function improperly and confer risk for disease.
Environmental inputs have shown to be an important trigger for altered epigenetic
signaling. It has been well documented that the epigenome is highly susceptible to
environmental input and certain environmental exposures including cigarette smoking (
Lee & Pausova, 2013), pollutants or toxins (Ho et al., 2012), exercise (Voisin et al.,
2015), and diet (Anderson et al., 2012) alter DNA methylation patterns. Importantly for
psychologists, thousands of studies in the field of behavioral epigenetics have also
demonstrated the link between psychosocial stressors and DNA methylation across
developmental stages (for a review of maternal prenatal stressors see Sosnowski et al.,
2018; for a review of child maltreatment see Lutz & Turecki, 2014).
8

Due to the vital role that adverse life experiences play in the development of
mental illness, epigenetic processes present a novel way to unify the biological and
environmental origins of risk and resilience to psychopathology. Epigenetic changes
including DNA methylation have emerged as potential mechanisms that can both capture
the effects of stressful early life experiences and explain their propagation into adulthood.
The promise of a mediational model suggests that exposure to stressful early life
experiences during crucial periods of development sets individuals on relatively stable
biological trajectories via epigenetic mechanisms that then alter key systems such as the
stress response and immune systems, that result in the development and maintenance of
psychopathology later in life.
A seminal study using an animal model done by Weaver and colleagues (2004)
demonstrated the potential of this mediational framework in describing how early life
experiences can lead to behavioral phenotypes via epigenetic mechanisms. Results
showed that pups who were raised by anxious, low nurturing mothers (i.e. characterized
by decreased pup licking, grooming, and arched-back nursing) were more likely to
demonstrate a stable, anxious phenotype into adulthood than pups who were raised by
nurturing mothers. Pups who were neglected had higher levels of DNA methylation in the
region of the glucocorticoid receptor gene (NR3C1), had decreased transcription factors,
and subsequent gene expression in the hippocampus. NR3C1 is integral in the modulation
of the HPA axis and a key player in the stress response system. This was the first study to
demonstrate the link between early life experiences and an animal model of
psychopathology via epigenetic mechanisms.
Prenatal Calibration of Risk: Fetal Programming Hypothesis
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It is clear that adverse environmental inputs early in the lifespan have long range
health consequences into adulthood. In the past couple of decades, researchers have been
asking the question of exactly how early in development can risk be embedded. A vast
empirical base suggests that prenatal exposure to environmental stress can set a child on
disease trajectories with long lasting effects into adulthood before the child is even born.
A seminal example of this is findings from the Dutch Hunger Winter cohort (N = 2141),
conceived during a famine in the Netherlands in 1944 as a result of WWII and followed
up in adulthood. Results showed that prenatal exposure to famine in general lead to
higher rates of Type II diabetes in middle adulthood and exposure to famine particularly
in early gestation was linked to coronary heart disease, breast cancer, increased stress
responsiveness, and higher rates of obesity (Roseboom et al., 2006).
The long-lasting effects of prenatal exposures have been explained by the “fetal
programming hypothesis” which posits that risk for psychopathology later in the lifespan
is biologically programmed in the uterine environment during a period of rapid
neurodevelopment when the fetus is particularly susceptible to environmental influences
(Barker, 1995). The fetus incorporates signals about the maternal environment including
diet and stress into its developmental trajectory via epigenetic changes related to
neurodevelopment of key brain areas and networks in an effort to most adaptively match
development to future postnatal environment (Barker, 1995; Gluckman, Hanson, Cooper,
& Thornburg, 2008). Within this framework, vulnerability to psychopathology has been
described as the “three hit hypothesis.” Genetic predisposition is hit 1, the prenatal
environment is hit 2, both calibrate susceptibility to hit 3, life experiences and exposures
postnatally (Daskalakis et al., 2013). In recent follow up studies of the Dutch Hunger
Winter, researchers found that even 60 years after the event, siblings who were prenatally
10

exposed to the famine showed lower DNA methylation of the insulin like growth factor 2
(IGF2), a gene essential in fetal growth and development, compared with their unexposed
same-sex sibling (Heijmans et al., 2008). Using an epigenome-wide approach,
researchers identified additional differentially methylated genes associated with prenatal
famine exposure including the insulin receptor gene (INSR), a gene involved in prenatal
growth and insulin signaling, and the carnitine palmitoyltransferase 1A gene (CPTA1),
which is involved in fatty acid oxidation (Tobi et al., 2014).
The fetal programming hypothesis has also been used to understand the early
embedding of risk for psychopathology as well. A large number of studies have shown
that exposure to prenatal maternal psychopathology such as depression and anxiety is
associated with both internalizing and externalizing behavioral outcomes in children such
as depression, anxiety, ADHD symptoms, and conduct problems, above and beyond the
quality of the child’s postnatal environment (Barker et al., 2011; O’Connor et al., 2002;
O’Donnell et al., 2014; Van den Bergh & Marcoen, 2004). Prenatal exposure to maternal
mood disorders may account for 10–15% of the variance in children’s behavior problems,
accounting for concurrent levels of maternal mood symptoms (Glover, 2015). A wealth
of research has emerged studying the process by which prenatal stressors via DNA
methylation confer risk for psychopathology later in the lifespan. One study found that
higher perceived maternal stress in the second trimester was associated with higher DNA
methylation of hydroxysteroid 11-beta dehydrogenase 2 (HSD11B2), a gene that is
integral in the deactivation of cortisol, which was in turn associated with a lower score on
an index of fetal neurodevelopment in the third trimester (Monk et al., 2016). Another
found that decreased prenatal maternal mood was related to increased DNA methylation
in NR3C1 in the newborn, which was associated with increased cortisol response at 3
11

months (Oberlander et al., 2008). Utilizing the ALSPAC sample, researchers found
variation in DNA methylation at seven loci across the epigenome in cord blood
differentiated children who go on to develop early-onset conduct problems in middle
childhood (Cecil et al., 2018). The prenatal period may be an essential stage of
development in which to study epigenetic processes as embedding risk for
psychopathology as the rate of DNA synthesis is high and the epigenetic marks needed
for normal tissue differentiation and development are being established (Dolinoy et al.,
2007).
Applying Epigenetics to Psychological Phenotypes
The study of epigenetic alterations as mechanisms for disease was first
appreciated in cancer research where DNA methylation is among the most common
somatic errors involved in carcinogenesis and accounts for a high proportion of tumor
suppressor gene inactivation. Momentum has also been building in studying DNA
methylation in the context of aging and other disease including autoimmune disorders,
cardiovascular diseases, diabetes, and neurodegenerative disorders. Epigenetic research
in the biomedical world commonly employs the case-control study design where a
population is divided into a “disease” group and a “non-disease” group to examine
epigenetic differences between the two. In translating technological advances in
epigenetics from the biomedical world, developmental psychopathologists have largely
contextualized psychological phenotypes within the same biomedical disease model,
frequently using convenience sampling of adults (i.e. dividing a sample into individuals
that meet criteria for depression and comparing their epigenetic profiles to controls). Due
to their heterogeneity and comorbidity, psychological phenotypes are uniquely complex
in their classification and measurement and are not automatically amenable to the same
12

methodologic framework. Many psychological disorders are better understood as
occurring on a continuity of “normative” human experiences rather than discrete disease
entities and psychological disorders have more complex continuity and discontinuity over
time.
It is clear that the roots of both psychological and biomedical disorders can be
traced back to early life development. However, unlike most biomedical disorders studied
through the lens of epigenetic alterations, many psychological disorders have their initial
onset in childhood. According to the World Health Organization, externalizing or
impulse-control disorders across the world have the earliest onsets with median 7-9 years
for ADHD, 7-15 for Oppositional Defiant Disorder (ODD), 9-14 years for conduct
disorder. Research has shown that specific phobias tend to being in early to middle
childhood, social anxiety in early to mid-adolescence, obsessive compulsive disorder in
mid to later adolescence, and panic disorder in early adulthood (Kessler et al., 2005).
Studies on depression have shown that the prevalence rates are generally low in children
and grow to near-adult prevalence levels in adolescence (Merikangas et al., 2010).
Because most adult psychopathology has its origins in childhood, it is imperative that in
seeking biological mechanisms for the origins of psychological disease, researchers must
examine epigenetic mechanisms early in the lifespan and in the developmental contexts
in which these disorders initially occur. Utilizing longitudinal designs not only allows
researchers to study epigenetic changes in a relevant sensitive period, they also have the
advantage of establishing temporal order of epigenetic changes and disease outcome. In
case-control designs, DNA methylation and disease outcome is usually measured
concurrently, which limits interpretations of epigenetic changes as causative as it is
equally reasonable to assume that epigenetic changes can be interpreted as a biomarker of
13

“wear and tear” of a debilitating and often chronic mental illness rather than a causal
mechanism that explains its origin.
Therefore, the central aim of this thesis was to apply epigenetic theory,
methodology, and technology to clinically relevant psychological phenotypes in a
longitudinal framework that take into account phenotypic complexity and developmental
context.
CHAPTER 3: Description of the Study Population
Description of the Avon Longitudinal Study of Parents and Children (ALSPAC)
cohort
The Avon Longitudinal Study of Parents and Children (ALSPAC) also known as
“Children of the 90s” is an ongoing epidemiological study of children born in the city of
Bristol in the United Kingdom in the 1990s (see cohort profiles Boyd et al., 2013; Fraser
et al., 2013). The recruitment sample (N=14, 541) was all women residing in the Avon
county catchment area with an expected date of delivery between April 1, 1991 and
December 31, 1992. Data collection is still ongoing as ALSPAC participants transition
into adulthood as well as efforts to gain information on the next generation.. Recruitment
for the multi-generational cohort ALSPAC-G2 or “Children of Children of the 90s”
began in 2012 and aimed to recruit all children of the (now adult) original ALSPAC
children to continue recurring biological, psychosocial, and physiological assessments on
the next generation and examine intergenerational connections to health and disease.
The families have been followed up with frequently, with 68 data collection time
points between birth and age 18 including self, mother, father, and teacher reports. Selfreported questionnaire measures focused on mother’s health included mental health
(focusing largely on anxiety and depression), reproductive health (e.g. contraception,
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menstrual patterns, repeatedly assessed pregnancies), cardiometabolic health (e.g.
hypertension, cholesterol, musculoskeletal health (e.g. falls and fractures, arthritis),
respiratory health (e.g. asthma, bronchitis), and health-related behaviors including
substance use, diet, physical acitviity. Environmental measures include life course
characteristics (e.g. retrospective measures of their child abuse and/or neglect, parental
socioeconomic status and childhood housing conditions) and current life stressors
including social support networks and romantic relationship functioning.
Self-reported child questionnaires included environmental measures assessed
throughout the lifespan include diet, physical activitiy, hosuing, socioeconomic
background, life stressors, air polluants (e.g. cigarette smoking in the home, home close
to heavy traffic), and school environment. Physiological measures include
anthropometry, blood pressure, pulse rate, lung function, fitness, skin, eye, and dental
observations. Cognitive measures include IQ, speech and language ability, motor skills,
and reading abiliy. As the ALSPAC children matured into pre-adolescennce, puberty and
mensutration measures were collected. Psychosocial questionnaires focused on gender
bhavior, self-esteem, peer relationships, romantic relationships, eating disorders, and
alcohol and drug use. Psychopathology information was also collected assessing
internalizing symptoms (e.g. mood and anxiety disorders), externalizing symptoms (e.g.
ADHD, conduct and impulse control diosrders), as well as symptoms related to bipolar
disorder and psychosis. The study website contains details of all the data that is available
through a fully searchable data dictionary: http://www.bris.ac.uk/alspac/researchers/dataaccess/data-dictionary/.
Like with all longitudinal cohorts, attrition over the years has been a challenge.
Attrition rates were highest in the early neonatal stage of the study (66%) and decreased
15

over time, ranging from 48%-60% in childhood, 49% in adolescence, and 39.44% in
transition to adulthood. However, mean attrition rates largely exaggerate the numbers of
pariticpants lost to follow up due to the high volume and frequency of data collection
points and different response patterns across nearly three decades. For example, some
participants return to the study after years of no follow up. In fact, it seems that ALSPAC
has a core of 3,000 devoted families that have completed all possible assessments, with
close to 5,777 families completing 75% of all assessments throughout a 30 year period.
The ALSPAC cohort presents an unprecedented breadth and depth in assessment
of health across the lifespan in an epidemiological cohort. One major limitation of the
cohort, however, is the under-representation of non-White minority ethnic groups (2.2%
of ALSPAC mothers were non-white) which limits external validity when generalizing
findings to other populations. Under-representation is laregly due to the demographic
profile of the original catchment area of Avon (4.4% non-White mothers) as well as the
effects of differential attrition based on socioeconomic status. Children lost to follow-up
are more likely to have a lower educational attainment, are more likely to be eligible for
free school meals, and are more likely to be male. In order to address differential attrition
and enhance the data resource, researchers used data linkage to link participants to
publically available public health and administrative records including medical records,
education records, economic, emplyment and social support records, criminal
convictions, and neighborhood data.
Description of the Data Resource Profile: Accessible Resource for Integrated
Epigenomic Studies (ARIES)
In 2012, a sub-project of ALSPAC named the Data Resource Profile: Accessible
Resource for Integrated Epigenomic Studies (ARIES), was established to create a
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population-based resource of DNA methylation data with the aim to understand the role
of DNA methylation in health and development in the ALSPAC cohort (see cohort
profile Relton et al., 2015). Based on available retrospective DNA sampling, 1,018
mother-child dyads (50% female offspring) from the original ALSPAC cohort were
chosen to obtain epigenome-wide DNA methylation samples using the Illumina Infinium
HumanMethylation450 BeadChip (450 K) array. DNA samples for offspring were
available at three separate time points: at birth and extracted from cord blood drawn from
the umbilical cord upon delivery, at mean age 7.5 years, and at mean age 15.5 years, both
extracted from peripheral blood. Maternal samples were collected during pregnancy at
mean 26 weeks gestation and again approximately 15-17 years later. The ARIES subsample is considered to be reasonably representative of the main study population.
Though mothers included in ARIES were slighltly older, more likely to have a nonmanual occupation, and are less likely to have smoked during pregnancy.
The ALSPAC cohort sample is one of a kind as its large scale and in-depth rich
analysis of mental and physical health across the lifespan is unprecedented in
epidemiological studies. Due to recurrent measuring of key phenotyoes and genetic and
biological samples at multiple time points, this data set is uniquely suited to explore
questions of epigenetic origins of risk and resilience for psychopathology within a
developmental and ecological framework.
Processing of the ARIES DNA Methylaton Data
DNA methylation data processing using the Illumina 450k array was conducted at
the University of Bristol. DNA samples from all participant ages (cord, middle
childhood, adolescence) were distributed across slides using a semi-random approach to
minimize the possibility of confounding due to batch effects. DNA methylation data went
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through several quality checks to ensure accuracy. In order to remove sample
mismatches, genotype probes were compared with SNP data from the same indidivudal
in the ALSPAC sample and samples were flagged if there was a sex mismatch based on
X-chromosome methylation. The Illumina 450k array also has 850 quality control probes
on each array that asses various aspects of the data collection process to determine the
status of staining, extension, hybridization, target removal, bisulfite conversion,
specificity, non-polymorphic and negative controls. Samples failing quality control were
repeated and, if unsuccessful, excluded from further analysis. Micro-arrays have been
shown to have very strong batch effects that can mask true biological differences between
samples. Statistical controlling for batch effects during the data analysis phase is not
sufficient and data needs to be initially normalized to remove any artificial variation
between samples. There are several statistical methods that can be used to normalize the
450k array using packages in R.
There are two confounders present in the set-up of the Illumina microarray:
polymorphic probes and cross-reactive probes. Polymorphic probes are probes that target
CpG sites that are on or near SNPs. Since the Illumina platform uses quantitative
genotyping of C/T SNPs, probes with polymorphisms at the target C or G have the
potential to confound a difference in genotype rather than a difference in DNA
methylation. By utilizing genotype and DNA methylation information from the same
individuals, researchers have found that DNA methylation profiles of probes located on
or near a SNP were typically explained by patterns of the SNP genotype and do not
reflect any underlying epigentic mechanisms (Chen et al., 2013; Price et al., 2013).
Cross-reactive probes are probes that hybridize to multiple genomic locations that are
similar. The level of DNA methylation at these probes likely reflects a combination of
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DNA methylation at the various locations to which they hybridize (Chen et al., 2013;
Price et al., 2013) . Both polymorphic and cross-reactive probes have been annotated by
researchers who recommend removal of these probes for analyses examining differences
in DNA methylation.
Like most exisitng cohort studies, ALSPAC has been utilizing stored whole blood
samples for DNA methylation analyses. Whole blood is a heterogenuous collection of
different cell types, which carry their own unique DNA methylation profile as a blueprint
for cell differentiation (Reinius et al., 2012). For each individual, the proportion of cell
types within their specific blood sample can vary widely, which in turn can confound
DNA methylation measurement. The overwhelming majority of the ALSPAC DNA
samples did not have whole blood cell counts assessed prior to DNA extraction and
therefore a post hoc correction is necessary. First, the fraaction of CD8, CD4, NK, B,
monocyte, and granulocyte cells in each individual is estimated and those estimated cell
type proportions serves as covariates in any subsequent analyses. For cord blood obtained
at birth, the Bakulsi method was used (Bakulski et al., 2016). For peripheral blood
obtained in adolescence, the Houseman method was utilized (Houseman et al., 2016).
Introduction to Empirical Chapters

The first study describes a manuscript titled “Variation in DNA Methylation of
the Oxytocin Receptor Gene Predicts Children's Resilience to Prenatal Stress” published
in Development and Psychopathology in 2017. It is a candidate gene approach examining
epigenetic changes in the oxytocin receptor gene (OXTR) as it relates to resilience to
prenatal stress. It is an early training step into behavioral epigenetic research, theory, and
methods. The second, not yet published, study represents a more in-depth and
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methodologically sophisticated epigenome-wide approach examining epigenetic
correlates of depression trajectories in adolescence and follow up gene annotation, gene
network analyses, and regional analyses.
CHAPTER 4: Variation in DNA Methylation of the Oxytocin Receptor Gene
Predicts Children's Resilience to Prenatal Stress
Introduction
Resilience is defined as successful emotional, behavioral, or social adaptation or
adjustment despite experience of significant adversity, stress, or trauma (Luthar et al.,
2000; Rutter, 2012). In children, researchers have operationally defined this adaptation in
a myriad of ways such as mastering normative developmental tasks (Luthar et al., 2015),
absence of psychopathological outcomes (Martinez-Torteya et al., 2009) or functioning
that is “better than expected” given a level of exposure to risk (Kim-Cohen et al., 2004).
Some children show resilience across multiple domains of functioning. More commonly,
however, at-risk children show resilience in one domain of functioning but not in others
or they may be resilient at one time period but not another (Masten, 2013). Thus,
resilience as a construct may be better defined as a dynamic process (not a trait or
characteristic) that depends on the balance of risk and protective factors available to an
individual at a given point in time (Jaffee et al., 2007; Rutter, 2006, 2012). Understanding
the mechanisms that promote resilient functioning in addition to the processes that confer
risk for psychopathology, and the dynamic balance between them, is essential to
understanding how normative and maladaptive developmental trajectories form.
Researchers have long posited the importance of adverse life events during early
critical periods in understanding risk and resilience. The prenatal period, specifically, is
one in which the fetus is especially vulnerable to a wide range of environmental
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exposures that have the potential to confer risk for emotional, cognitive, and behavioral
problems in childhood (Braithwaite et al., 2014; Rice et al., 2007). A large number of
studies have shown that exposure to prenatal maternal psychopathology such as
depression and anxiety is associated with both internalizing and externalizing behavioral
outcomes in children such as depression, anxiety, ADHD symptoms, and conduct
problems (Barker et al., 2011; O’Connor et al., 2002; O’Donnell et al., 2014; Van den
Bergh & Marcoen, 2004). Prenatal exposure to maternal stressful life events, such as
death of a close relative or friend, divorce, marital problems, and job loss, has also been
linked to ADHD, behavioral problems, and internalizing symptoms (Laucht et al., 2000;
Pawlby et al., 2009; Ronald et al., 2010). It is clear that a range of stressors during the
prenatal period increases risk for child psychopathology. However, not all children
exposed to environmental stressors in utero go on to develop psychopathology and some
children seem to be less vulnerable than others. There are several hypotheses that can
potentially account for this differential vulnerability. One possibility is that a supportive
postnatal environment can attenuate or reverse the effects of prenatal stress. For example,
researchers have found that sensitive caregiving moderates the effect of prenatal maternal
stress on infant fearfulness (Bergman et al., 2008) and cognitive outcomes (Bergman et
al., 2010)
A second possibility is that individual differences in genotype confer protection
against prenatal stressors. For example, researchers have found that variation in the
glucocorticoid receptor gene (NR3C1), a gene integral to the functioning of the
hypothalamic-pituitary-adrenal (HPA) axis which is involved in stress reactivity,
moderated the effect of prenatal maternal psychological symptoms on later emotional and
behavior problems, such that children whose mothers were depressed or anxious when
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they were pregnant with the child had an increased risk of emotional and behavioral
problems at age 3 if they possessed the minor allele C (CC or CG), but not if they were
homozygous for the major allele (GG) (Pluess et al., 2011). Using data from 1513
children in the Generation R cohort, Pluess and colleagues (2011) found that infants
whose mothers were more anxious during pregnancy had higher scores on a measure of
negative emotional temperament than infants whose mothers were not anxious and this
effect was significantly stronger for infants who carried the short ‘s’ form of the serotonin
transporter gene (5-HTTLPR) compared with infants who carried two copies of the long
‘l’ form of the gene. In addition, Oberlander and colleagues (2010) found that prenatal
exposure to maternal anxiety predicted internalizing symptoms in children with 2 copies
of the 5-HTTLPR ‘s’ allele (but not in children who carried the ‘l’ allele). In contrast, a
mother’s anxiety during pregnancy predicted her child’s externalizing problems only if
her child had 2 copies of the ‘l’ allele and not if the child carried at least one ‘s’ allele
(Oberlander et al., 2010).
In addition to identifying structural variants in the genome that buffer against the
effects of prenatal stress, new research in the field of behavioral epigenetics has started to
elucidate the underlying biological mechanisms of the relationship between stress
exposure and later developmental outcomes, including emotional and behavioral
problems. Epigenetic research sits at the intersection of social and biological explanations
for developmental psychopathology and has enormous potential for describing how
stressful life events “get under the skin” and have lasting effects on mental and physical
health. The epigenome describes the chemical switches that sit on top of genes and
modulate gene expression. Stress-induced epigenetic modifications are typically
measured by examining DNA methylation, where methyl groups are added to cytosine22

guanine-phosphate (CpG) sites on the regulatory or promoter regions of genes to silence
transcription factors or block access to recognition elements of a gene (Bick et al., 2012).
DNA methylation is typically related to lower gene expression in promoter regions.
However, DNA methylation in other genomic regions can have the opposite effects on
expression (e.g. gene body) and there is little known about the functional role of DNA
methylation in other locations such as the intergenic region (Jones, 2012). Studies have
shown that DNA methylation patterns are under significant control – as evidenced by the
discovery of a large number of methylation quantitative trait loci (mQTL; Gaunt et al.,
2016; Jones, 2012) – but are also sensitive to environmental influences (McGowan &
Roth, 2015). Although the environment modifies the epigenome throughout the lifespan,
there is some evidence that the in utero environment has the largest effect (Billack et al.,
2012). These prenatal effects have been largely interpreted in terms of the fetal
programming hypothesis in which the fetus adapts its phenotype – such as stress
reactivity or metabolism – to what it anticipates its postnatal environment to be on the
basis of the biological cues from the mother’s environment (Gluckman et al., 2008b).
The majority of studies investigating the association between prenatal exposure to
maternal stress and methylation have focused on NR3C1. Prenatal stressors such as
maternal depression (Conradt et al., 2013a; Hompes et al., 2013), exposure to intimate
partner violence (Radtke et al., 2011) and exposure to war (Mulligan et al., 2012) have
been associated with increased methylation of NR3C1 at birth. There is, however,
variability in these methylation profiles, even among newborns whose mothers reported
high levels of stress and this variability may be predictive of children’s risk for emotional
or behavioral health problems versus their resilience. To date, few biologically informed
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prospective studies have explored gene-specific methylation patterns in the context of
resilience. We focus on methylation of the oxytocin receptor gene (OXTR).
Oxytocin is an essential neuropeptide and hormone in the regulation of social and
affiliative behavior such as empathy, attachment, bonding, emotion recognition, and
processing of social stimuli (Jack et al., 2012). Oxytocin has also been shown to have
anxiolytic effects by dampening physiological, hormonal, and brain-level responses to
stressful or aversive signals (Heinrichs et al., 2009). Thus, stress-related epigenetic
changes in the oxytocin system may confer risk for the development of psychopathology
by shaping socio-emotional, socio-cognitive, and stress response systems that underlie
temperament and children’s relationships with peers and adults.
It is biologically plausible to predict that prenatal (or postnatal) stressors would be
associated with increased DNA methylation and, in turn, increased emotional and
behavioral problems. That is, if DNA methylation acts as a gene silencer, increased
methylation in the promoter region of the gene would result in lower messenger RNA
(mRNA) levels, blocking of transcription factors, and in turn, decreased gene expression
and decreased circulating oxytocin in the blood. Indeed, a number of studies have found
evidence for these relationships. For example, increased OXTR methylation leads to
decreased OXTR mRNA expression in hepatoblastoma human cells (Kusui et al., 2001)
and in murine cells (Mamrut et al., 2013) in the promoter region of the gene. Gregory and
colleagues found increased promoter region OXTR methylation in peripheral blood as
well as in temporal cortex tissue in individuals with autism compared with controls.
Increased methylation resulted in a 20% reduction in mRNA expression (Gregory et al.,
2009) .
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Consistent with the possibility that OXTR methylation may be a mechanism by
which prenatal exposures increase risk for psychopathology, Dadds and colleagues (2014)
found that elevated methylation in OXTR in a sample of 4- to 16-year-olds was associated
with lower levels of circulating oxytocin and higher levels of callous-unemotional traits.
Similarly, in a sample of youth with early-emerging and persistent conduct problems,
Cecil and colleagues found that higher methylation at birth at the OXTR locus was
associated with higher levels of callous-unemotional traits at age 13, although the effect
was only observed in youth with low levels of internalizing problems (Cecil et al., 2014).
Moreover, mothers’ reports of behaviors that might have caused stress to themselves or
the fetus (e.g., their own criminal behavior, their partner’s criminal behavior, their own
psychopathology and substance use) were associated with elevations in OXTR
methylation at birth.
Despite the plausibility of a pathway by which prenatal stressors lead to increased
OXTR methylation, a number of studies have found the inverse relationship between
OXTR methylation and prenatal stress as well as psychological outcomes. For example,
one study focusing on prenatal stress found that the more life-changing stressful events a
mother experienced when she was pregnant, such as being a victim or witness of assault
or experiencing the severe illness or death of a loved one, the lower the OXTR
methylation levels in cord blood at birth (Unternaehrer et al., 2015). Reiner and
colleagues found that depressed women had lower OXTR exon 1 DNA methylation levels
compared to non-depressed women (Reiner et al., 2015). Moreover, Ziegler and
colleagues found in a sample of adults that decreased OXTR methylation was associated
with a diagnosis as well as symptoms of social anxiety disorder, increased cortisol
responses to a stress test, and increased amygdala responsiveness during social anxiety
25

word processing (Ziegler et al., 2015). In addition, in a brain imaging study, researchers
found that higher OXTR methylation was related to increased brain activity in areas
associated with social perception such as the temporoparietal junction and the dorsal
anterior cingulate cortex (Jack et al., 2012). Thus, the evidence is mixed as to whether
prenatal stressors are associated with increased or decreased OXTR methylation and
whether individual differences in OXTR methylation are associated with positive or
negative child (or adult) outcomes. Direction of effects could be highly dependent on the
location of the probes examined.
The present study is the first to make use of a longitudinal design to examine if
OXTR methylation at birth can differentiate resilient and non-resilient youth as measured
by hyperactivity, conduct problem, and emotional problem outcomes in mid-childhood.
Additionally, a strength of the study is that only children with pre- and post-natal
adversity were included which ensures that resilience is not driven by differences in the
quality of the postnatal environment. Given mixed findings in the literature about the
direction of the relationship between stress in pregnancy and methylation levels at birth
as well as the relationship between methylation levels and later behavior, we do not
propose a directional hypothesis. Understanding plasticity at this critical period in
development can help us examine how early stress can “get under the skin” and alter
developmental trajectories. We hypothesize that this variability will be predictive of
which newborns grow up to have low levels of psychopathology, despite their exposure
to prenatal risk factors.
Methods
Participants
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The Epigenetic Pathways to Conduct Problems Study consists of a subsample of
youth (n = 339, 50% female) nested within ALSPAC and ARIES with established
trajectories of conduct problems from ages 4 to 13 (Barker & Maughan, 2009) and have
epigenetic data at birth and/or childhood. This subsample is comparable to the full
trajectory sample (n = 7,218) in terms psychiatric comorbidity (Barker et al., 2010).
DNA methylation measures were available for 326 youth at birth. Children with missing
ethnicity information were removed, leaving a total sample of 321. Except for factor
analyses, in which we used data from all youth, the present study only included youth
who scored above the sample average on our measure of prenatal and postnatal (birth to
age 7) environmental risk exposure. Although exposure to prenatal risk was the focus of
our study, we wanted to ensure that differences in the postnatal environment did not
account for any observed associations between methylation profiles at birth and resilience
in middle childhood. These measures of prenatal and postnatal risk are described below
in the section “Environmental Risk.” The final analytic sample was n = 91, all of whom
had complete data including DNA methylation at birth, had been exposed to pre- and
post-natal adversity, and for whom information on emotional and behavioral outcomes
was collected. See Figure 1 for a flow chart representing which youth were included in
the analysis sample.
Measures
DNA Methylation data at Birth. DNA methylation was assayed according to
standard protocol described in the Introduction section of this thesis (p. 19-22). Samples
were quantile normalised using the dasen function within the wateRmelon package
(wateRmelon_1.0.3; 19) in R and batch corrected using the ComBat package (Johnson et
al., 2007).
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We extracted data for probes located within the OXTR CpG island (n = 12), as
this area has been previously investigated and shown to play a key role in modulating the
transcriptional activity of OXTR (Kusui et al., 2001). For each probe, methylation levels
were indexed by beta values (corresponding to the ratio of methylated signal divided by
the sum of the methylated and unmethylated signal). Factor analysis was used to reduce
the 12 OXTR probes into a smaller set of factors, which accounted for shared variance
between them. A 3-factor solution showed the best fit to the data as well as good
temporal stability. See Supplement 1 and 2. We present findings relating specifically to
Factor 1, three probes located in the 5'UTR region – Probe 1 (cg00078085), Probe 5
(cg03987506), and Probe 10 (cg12695586) – because Factor 2 and 3 scores were not
significantly associated with any type of resilience.
Environmental Risk. The prenatal risk score comprised items that were
reported by mothers and summed to create 4 conceptually distinct but related domains: (i)
Life events (e.g. death in family, accident, illness), (ii) Contextual risks (e.g. poor housing
conditions, financial problems), (iii) Parental risks (e.g. maternal psychopathology,
criminal involvement and substance use), (iv) Interpersonal risks (e.g. intimate partner
violence, family conflict). Measures of post-natal environmental risk were created for the
early childhood (birth-age 7) and middle childhood (age 8-9) periods. These included all
domains represented in the prenatal risk composite as well as a measure of Direct
victimization (e.g. child bullied by peers or physically hurt; available only postnatally).
Risk domains were positively and significantly correlated, both within and
between developmental periods, with the majority of correlations ranging from r =.20.40. For the prenatal and postnatal periods, we used confirmatory factor analyses (CFAs)
to assess the internal reliability of the risk domains and to extract one global cumulative
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risk score for each developmental period, showing good model fit. Higher scores indicate
greater environmental risk exposure. See Supplement 3 for full item descriptions, details
of inter-correlations between risk domains and factor analysis fit indices. To ensure that
youth who were defined as resilient or non-resilient had been exposed to at least some
moderate level of environmental risk, the sample was restricted to youth who scored
above the mean on the measures of prenatal and postnatal cumulative environmental risk,
as described in the Participants section.
Internalizing and Externalizing Problems. Repeated assessments of conduct
problems, hyperactivity, and emotional problems were made at ages 4, 7, 8, 10, 12, and
13 via maternal reports on the Strengths and Difficulties Questionnaire (SDQ)
(Goodman, 1997). The SDQ is a widely used screening instrument with reliability and
validity demonstrated in a large national sample (Goodman, 2001). The SDQ comprises
five subscales, each consisting of five items rated by mothers as ‘certainly true’,
‘somewhat true’, or ‘not at all true’. In the current study, we utilized the conduct
problems subscale (e.g., ‘often fights with other children or bullies them’, ‘often lies or
cheats’), the hyperactivity/inattention subscale (e.g., ‘restless, overactive, cannot stay still
for long’, ‘constantly fidgeting or squirming’) and the emotional problems subscale (e.g.,
‘often unhappy, down-hearted or tearful’, ‘many worries, often seems worried’). In order
to obtain more robust and reliable estimates of symptomatology, we performed a
confirmatory factor analysis for each of the three subscales that included data from age 4
to 13, so as to generate a single factor score for each subscale that accounted for shared
variance across time points. We also created a ‘global symptomatology’ factor score
combining all three SDQ subscales as a measure of more general overall functioning. See
Figure 2 for summary statistics as well as full details of the confirmatory factor analysis.
29

Psychosocial Functioning. We used factor scores from the peer problems (e.g.
‘rather solitary and tends to play alone’, ‘generally liked by other children’) and prosocial
behavior (e.g. “considerate of other people’s feelings’, ‘kind to younger children’)
subscales from the SDQ. We also utilized a six item callous-unemotional traits
questionnaire completed by mothers when the child was 13 (e.g., ‘makes a good
impression at first but people tend to see through him/her after they get to know him/her’,
and ‘shallow or fast changing emotions’) (Moran et al., 2008). Items were rated on a
three-point scale ranging from ‘not true’ to ‘certainly’ true. Social cognition was assessed
using the 12-item Social Communication Disorder Checklist (Skuse et al., 2005)
completed by mothers when the child was 7 years old. Items included for example: ‘not
aware of other people’s feelings’, ‘does not notice the effect of his/her behavior on other
members of the family’. Higher scores indicate lower social cognition.
Classification of Resilience. In order to classify the sample into resilient (1) and
non-resilient (0) groups, we conducted four ordinary least squares regressions to predict
(i) global, (ii) conduct problems, (iii) hyperactivity, and (iv) emotional problems,
respectively, from the prenatal cumulative risk factor score. We utilized residuals from
these regressions to classify youth into resilient and non-resilient groups in each domain.
Specifically, youth with negative residual scores were classified as resilient (indicating
that they had lower-than-predicted levels of psychopathology, given their exposure to
prenatal risk) and youth with non-negative residual scores were classified as non-resilient
(indicating that they had predicted or higher-than-predicted levels of psychopathology,
given their exposure to prenatal risk). One subject with conduct, hyperactivity, and global
symptomatology residual scores > 3 s.d. from the mean was removed from all the
analyses. Retention of the outlier results in a non-normal distribution of resilience
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residuals although findings remain unchanged with the subject’s inclusion. For all
domains, the distributions of the residuals were normal. See Figure 3 for resilience
classification.
For resilience as defined by global problems, n = 44 (48%) youths were classified
as resilient and n = 47 (52%) were not resilient. For resilience as defined by conduct
problem scores, n = 44 (48%) youth were classified as resilient and n = 47 (52%) were
not resilient. For resilience as defined by hyperactivity scores, n = 50 (55%) youth were
classified as resilient and n = 41 (45%) were not resilient. Finally for resilience as defined
by emotional problem scores, n = 50 (55%) youth were classified as resilient and n = 41
(45%) were not resilient.
Data Analysis
Factor analyses were conducted in Mplus version 6.1.128 and all other analyses in
SPSS 21. Regression analyses were conducted to test whether resilience (defined globally
and in terms of specific domains) was associated with the Factor 1 methylation score.
Post-hoc analyses were conducted to test whether resilience was associated with the
individual probes (Probes 1, 5, 10) that make up Factor 1. Covariates in all models
included sex and cell-type composition, estimated using the approach described in
Houseman and colleagues (2012). Analyses were bootstrapped 10,000 times.
Bootstrapping is advantageous with small samples as it derives an approximation of the
sampling distribution via repeated resampling of the available data to yield bias corrected
95% confidence intervals (CI). Significant associations were only presented if they
survived bootstrapped confidence intervals. Then, further analysis on any resilient
domains that had significant methylation results was conducted. Resilient and non-
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resilient groups in that domain were compared on additional psychosocial functioning
factors.
Results
As shown in Table 1, children who had lower conduct problem scores than
predicted given their exposure (to pre-natal environmental risk; i.e. resilient group) had a
higher OXTR methylation Factor 1 score than non-resilient children. In contrast, when
resilience was defined globally or in terms of hyperactivity or emotional problems,
resilience scores were not associated with OXTR methylation.
When examining the individual probes that make up the OXTR methylation factor
(Probes 1, 5, and 10), we found that youth who were resilient in terms of conduct
problems had significantly higher methylation levels across all three probes compared to
the non-resilient group. Interestingly, resilience as defined in terms of global problems
and hyperactivity problems predicted increased methylation only within one probe (Probe
5). Figure 4 highlights percent methylation differences across groups who were resilient
versus non-resilient in terms of conduct problems.
Table 2 provides descriptive information regarding the groups who were resilient
and non-resilient in terms of conduct problems. The groups did not differ in terms of
gender or in environmental risk at any developmental period (prenatal – age 9).
Furthermore, in an ANCOVA controlling for sex, we found that youth who were resilient
in terms of conduct problems also had lower hyperactivity, emotional problems and
callous-unemotional traits, higher prosocial behavior and better social cognition as
compared to youth who were non-resilient in terms of conduct problems. Thus, youth
who were resilient to prenatal risk in terms of having relatively low levels of conduct
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problems were functioning well across multiple domains that are typically compromised
when youth have conduct problems.
Post-hoc Analysis: Exploring Potential Genetic Influences. We explored
potential genetic factors that may influence the DNA methylation sites associated with
resilience to conduct problems. Because our sample was underpowered to directly
examine genetic polymorphisms (SNPs) affecting DNA methylation, we used the
mQTLdb resource (http://www.mqtldb.org/) to search for known methylation quantitative
trait loci (mQTLs) associated with our methylation sites of interest. The mQTLdb
database contains the results of a large-scale study based on the ARIES sample in
ALSPAC (from which our subsample is derived), characterizing genome-wide significant
cis effects (i.e. SNP within ±1000 base pairs of the DNA methylation site) and trans
effects (i.e. ±1 million base pairs) on DNA methylation levels across Illumina 450k
probes at five different life stages, including cord blood DNA methylation at birth (Gaunt
et al., 2016). Here, we searched for mQTLs based on results from the conditional
Genome-wide Complex Trait Analysis (GCTA), which was used to identify mQTLs with
the most representative, independent effect on each DNA methylation site in order to
account for linkage disequilibrium (Gaunt et al., 2016). Based on mQTLdb search, we
found that 2 out of 3 of Factor 1 probes (Probe 1 and Probe 10) were associated with
known cis SNPs, suggesting that DNA methylation levels across these sites are likely to
be under considerable genetic control. Interestingly, Probe 1 and Probe 10 are specific to
conduct problems, while Probe 5 was significant in both hyperactivity and global
problems. This suggests that these probes are likely to be influenced by genetic factors as
well as environmental adversity and may suggest a specific GxE effect for conduct
problems. See Table 3 for more details on SNP influences on Probe 1 and 10.
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Discussion
Our goal in this study was to examine whether variability in OXTR DNA
methylation profiles at birth predicted resilience as defined by psychopathological
outcomes that were better than expected based on prenatal risks. Consistent with our
hypothesis, Factor 1 methylation – as well as methylation of the individual probes (1, 5,
10) that make up the factor – was predictive of resilience to conduct problems in midchildhood. In contrast, OXTR DNA methylation profiles did not predict resilience in
domains of emotional, hyperactivity, and global symptomatology suggesting a potential
role for OXTR in the development of conduct problems in particular. This is consistent
with the fact that many social-cognitive processes such as empathy, attachment, bonding,
and emotion recognition are disturbed in children with conduct problems. In addition,
problems in social cognition associated with conduct-disordered behavior are typically
marked by deficits in oxytocin levels.
Children who were resilient in the conduct problems domain in mid-childhood
also had significantly fewer hyperactivity, emotional, and peer problems, higher levels of
prosocial behavior, better social cognition, and lower scores on a measure of callousunemotional traits compared with non-resilient youth. Thus, the group that was resilient
to conduct problems was broadly resilient across multiple domains. However, this was
probably not due to OXTR methylation profiles, which were not predictive of resilience
as defined by emotional or hyperactivity problems. One possibility is that children who
have fewer-than-expected conduct problems get along better with their peers, are both
innately more prosocial and observe higher levels of prosocial behavior in their
interactions with peers, and are thus buffered against the emergence of other forms of
psychopathology relative to children with higher levels of conduct problems (Oland &
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Shaw, 2005; Patterson et al., 1989). The role of OXTR DNA methylation in resilience
beyond the conduct problems domain remains unclear.
It is important to note that there were no significant differences between resilient
and non-resilient youths in levels of environmental risk in any of the developmental
periods from prenatal to age 9. This rules out the possibility that resilient youth exhibited
fewer conduct problems than non-resilient youth because they were exposed to less
environmental risk after they were born. If epigenetic modifications in OXTR are
consequences of exposure to stress, why would youth with similar levels of exposure to
prenatal adversity vary in terms of OXTR methylation profiles? Recently, researchers
have recognized that DNA methylation patterns may be allele-specific and the
relationship between exposure to stress and DNA methylation may be moderated by gene
variants. For example, one study found that adolescents that were homozygous for the lallele of 5HTTLPR and experienced more stressful life events had higher levels of
5HTTLPR methylation. Stressful life events were not associated with methylation for sallele carriers (van der Knaap et al., 2015). Another study found that decreased DNA
methylation in the FK506 binding protein 5 (FKBP5) gene depended on early childhood
abuse and the rs1360780 risk allele (Klengel et al., 2013). Although we could not
examine direct SNP effects because of small sample size, our post-hoc analyses using the
mQTLdb demonstrated that methylation of Probes 1 and 10 is significantly influenced by
SNPs rs62243375 and rs237900 respectively. Interestingly, our results showed that
Probes 1 and 10 were only related to conduct problems, while Probe 5 was related to
global problems and hyperactivity. This provides indirect evidence for OXTR genotype
moderating the relationship between adversity and DNA methylation in conduct
problems. However, studies examining allele specific DNA methylation effects earlier in
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child development, especially in the prenatal/neonatal period are lacking. More research
is needed to examine the integrative effects of OXTR genotype and DNA methylation on
the oxytocin pathway, especially during the critical prenatal period.
Increased methylation of OXTR is associated with decreased gene transcription
and protein expression, which theoretically represents the molecular building blocks for
behavioral phenotypes (Kumsta et al., 2013; Kusui et al., 2001; Mamrut et al., 2013).
Interestingly, our results showed that higher levels of DNA methylation of OXTR at birth
predicted resilience to conduct problems in mid-childhood. This pattern was unexpected
in light of results showing that elevations in OXTR methylation are also associated with
relatively high levels of callous-unemotional traits (Dadds et al., 2014; Cecil et al., 2014).
However, this traditional view has been recently challenged with more and more studies
finding an inverse relationship, highlighting the complexities in predicting behavioral
phenotypes from DNA methylation (Jack, Conolley, & Morris, 2012; Reiner et al., 2015;
Ziegler et al., 2015). In a human cohort, researchers found that only a minority of
individual CpG sites had significant negative correlations with mRNA signaling across
individuals and in a number of genes, higher DNA methylation was associated with
higher gene expression (Lam et al., 2012). This can also be because the relationship
between methylation, transcription, and expression can vary depending on the location of
the CpG site. Of note, the three probes in our study mapped onto the 5’ UTR region of
gene, where an inverse correlation between DNA methylation and mRNA expression has
previously been reported (Eckhardt et al., 2006). Thus, although we might theoretically
predict that higher methylation would be associated with a lack of resilience to conduct
problems, the mechanics of methylation are likely to be more complex than this.
Interestingly, our findings conflict with Cecil and colleagues (2014) work also
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using data from the ALSPAC sample in which they found that higher OXTR methylation
at birth was associated with higher callous-unemotional traits at age 13. Of note, Cecil et
al (2014) found this relationship in OXTR probes that make up Factor 2, while Factor 1
probes were not associated with callous-unemotional traits in their study. Furthermore,
the sample (N=39) was highly selected to include only youth who had early-onset and
persistent conduct problems and the relationship between higher OXTR methylation at
birth and callous-unemotional traits was only observed in the subgroup with low levels of
internalizing profiles. Thus, although our analysis sample and Cecil et al’s ostensibly
come from the same cohort, they reflect very different groups of children.
The present findings should be interpreted in light of a number of limitations. This
study focused specifically on DNA methylation of annotated probes located within the
CpG island of OXTR and it is likely that differences across groups may be found in other
genes (i.e. glucocorticoid or serotonergic pathways). Future studies may employ an
epigenome-wide approach that would enable researchers to examine group differences in
DNA methylation across the genome. In addition, we did not examine RNA expression
and cannot explore the functional relevance of the probes in regards to gene expression
and downstream biological mechanisms. However, we did select a region of OXTR that
has previously demonstrated to be functional in utero. Although we provided indirect
evidence for a potential GxE effect on DNA methylation via the mQTLbase data, we
could not directly test it due to sample size. In general, the findings are based on a
relatively small sample of youth, which limits statistical power to detect effects.
In summary, this is the first longitudinal study to examine the role of OXTR
methylation in resilience across multiple domains. Our findings show that OXTR
methylation at birth is exclusively related to resilience in the conduct problems domain in
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middle childhood. This may be potentially reflective of a GxE effect where genotype
moderates the relationship between environmental stressors and DNA methylation. These
findings highlight the importance of the prenatal period for the development of childhood
psychopathology and suggest a potential mechanism by which early experiences may be
biologically embedded. Because of the important role of oxytocin in social impairment,
understanding individual variations in OXTR methylation patterns might increase insight
into risk and resilience factors that can bridge translational efforts in treatment and
intervention approaches.
CHAPTER 5: A Longitudinal Epigenome-wide Analysis of Depression Trajectories
in Adolescence (Part 1)
Introduction
Major Depressive Disorder (MDD) in children and adolescents represents a major
worldwide public health burden. In the US, an estimated 3 million adolescents
experienced an episode of depression in 2017, representing around 13% of the US
population aged 12 to 17 (National Survey on Drug Use and Health, 2017). According to
the Centers for Disease Control and Prevention, in 2014 rates of death by suicide
surpassed deaths by traffic accidents among adolescents for the first time ever (Morbidity
and Mortality Weekly Report-MMWR, 2016). The suicide rates among even younger
youths (age 10 to 14) has doubled in the US between 2007-2014 (MMWR, 2016).
Depression in adolescence predicts major depressive disorder in adulthood, other mental
health disorders, substance abuse, suicide attempts, educational underachievement,
unemployment, and early parenthood (Fergusson & Woodward, 2002).
The etiology of depression is still not fully understood. Genetic factors confer risk
for the disorder with heritability of MDD estimated to be around 40%; but genetic
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variants explain only a small proportion of heritability (for reviews of GWAS depression
studies see Dunn et al., 2015; Tsang et al., 2017). Research has also shown that stressful
life events also confer risk for depression above and beyond heritability (Kendler,
Thornton, & Gardner, 2001; Kendler, Karkowski, & Prescott, 1999). Recent work
utilizing the UK BioBank (N = 126, 522) found that the SNP-based heritability of MDD
stratified by reported trauma exposure (24%) was much greater than MDD without
reported trauma exposure (12%) suggesting a complex relationship between genetic risk,
stressful life events, and MDD (Coleman et al., 2020).
Epigenetic research sits at the intersection between biological and environmental
explanations for the development of depression. Although the human genome is static,
the epigenome is dynamic and highly responsive to environmental input. The epigenome
describes the chemical switches that sit on top of genes and modulate gene expression by
either silencing or activating certain genes. Stress-induced epigenetic modifications are
typically measured by examining DNA methylation, where methyl groups are added to
cytosine-guanine-phosphate (CpG) sites (Jaenisch & Bird, 2003). Because the epigenome
is highly responsive to stress signals from the environment, modifications that produce
enduring changes in gene expression are a possible biological mechanism by which
stressful life events increase risk for depression. Our study aims to examine the etiology
of depression using epigenetic mechanisms through a developmental lens focusing on
two sensitive periods: in utero and adolescence.
Heterogeneity in Depression
Major Depressive Disorder is a heterogenous phenotype across many domains.
There is heterogeneity in presenting symptoms, both in terms of the type and
combination. For example, researchers found over a 1,000 unique depression symptom
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profiles in individuals diagnosed with MDD (N = 3707), representing only 3.6 patients
per profile (Fried & Nesse, 2015). Depression is also heterogenous in severity and is
better understood as a dimension ranging from normative response to life stress to a
severe disorder (Beach & Amir, 2003; Ruscio & Ruscio, 2000). Finally, depression is
also heterogeneous in clinical prognosis over time. Research has shown that depression
can be both a time-limited, single episode phenomenon and a recurring and chronic
lifetime disorder (Lorenzo-Luaces, 2015). It is clear that depression is better understood
as a heterogenous symptom cluster rather than a discrete, underlying condition with
demarcated boundaries and a homogeneous group of patients (Monroe & Anderson,
2015). However, in the search for biological vulnerabilities to MDD, research has largely
relied on a categorical, disease model when operationalizing depression. As a result,
despite decades of genetic, neurological, and biological research, slow progress has been
made in identifying reliable biomarkers for MDD. In an effort to take this phenotypic
heterogeneity into account, our study is the first to utilize a more dynamic measure of
depression using trajectories that reflect severity and course over time.
Sensitive Periods of Development
Adolescence. Although depression in childhood is rare (less than 3% prevalence
rate), there is a dramatic surge in depression rates during ages 13-17, with 17% of
individuals experiencing a depressive episode before the age of 18 (Ge et al., 1994;
Merikangas et al., 2010). There is a strong continuity of depression from adolescence into
adulthood, while most depressed pre-pubertal children do not grow up to be depressed
adults (Hankin et al., 2015a; Pine et al., 1999; Rutter et al., 2006). Therefore, adolescence
represents a particularly significant developmental stage in which to study biological
mechanisms underlying the development of depression.
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In utero. Researchers have long posited that the risk for psychopathology can be
embedded as early as the uterine period of development. With regards to depression
research, a consistent finding is that maternal depression during pregnancy significantly
increases risk for depression in offspring above and beyond postnatal maternal
depression, contextual factors, and overall postnatal environment (Barker et al., 2011;
Pawlby et al., 2009; Pearson et al., 2013; Plant et al., 2015) suggesting that the risk for
depression could be traced back to prenatal development.
Our study is able to assess the biological programming of depression risk through
a more developmentally relevant framework by examining epigenetic changes in
sensitive periods of development (in utero and adolescence) that have the biggest
potential to help us understand the causes of depression.
Literature Review of Epigenetics and Depression.
In the past ten years, there has been an explosion of DNA methylation studies
examining the depression phenotype. In the nascent stages of behavioral epigenetics as a
field, candidate gene approaches were most common. However, as the need for less
biased and more comprehensive approaches grew, epigenome-wide studies have become
more frequent, especially in the last five years. There are a number of reviews that
describe this vast literature. For a comprehensive systematic review of approximately 70
depression EWAS and candidate gene studies published before 2018 see Li and
colleagues (2019). For a systematic review more focused on work stress, burnout, and
depression see Bakusic and colleagues (2017). For a narrative review focusing on seven
specific candidate genes of depression see Chen and colleagues (2017). Finally, for a
more focused systematic review of monozygotic twin DNA methylation studies see
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Palma-Gudiel and colleagues (2020). Findings from some of these studies are broadly
summarized below.
Candidate Gene Studies. For candidate-gene approaches, using case-control
designs, the most frequently studied genes include brain derived neurotrophic factor
(BDNF), the glucocorticoid receptor gene (NR3C1), and the serotonin transporter gene
(SL6A4). The most robust candidate gene has been the BDNF with the majority of
studies finding hypermethylation of BDNF to be associated with depression (e.g.
Chagnon, Potvin, Hudon, & Préville, 2015; Choi et al., 2015; Fuchikami et al., 2011; Na
et al., 2016; Roy et al., 2017).. The BDNF gene provides the instructions for making
proteins often in the brain and spinal cord and are involved in promoting the growth,
maturation, and maintenance of neurons as well as regulating synaptic plasticity. There
have also been consistent associations of hypermethylation of SLC6A4 (e.g. Bayles et al.,
2013; Philibert et al., 2008; Shi et al., 2017; Zhao, Goldberg, Bremner, & Vaccarino,
2013) and NR3C1 (e.g. Roy, Shelton, & Dwivedi, 2017; Bustamante et al., 2016; Na et
al., 2014; Nantharat, Wanitchanon, Amesbutr, Tammachote, & Praphanphoj, 2015) and
depression. SLC6A4 codes for a protein that is involved in the regulation of serotonergic
signaling and NR3C1 is the receptor to which cortisol and glucocorticoids bind; both
have been implicated in mood and anxiety disorders. Other, less typically studied
candidate genes have also shown differences in DNA methylation in depressed
individuals including oxytocin receptor (OXTR; Chagnon et al., 2015; Reiner et al.,
2015), monoamine oxidase A (MAOA; Melas & Forsell, 2015), tescalin (TESC; Han et
al., 2017), and synapsin II (SYN2; Cruceanu et al., 2016).
Epigenome-wide Association Studies (EWAS). In the past few years, there has
been a substantial increase in EWAS depression studies. The majority of studies are
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cross-sectional, use the case-control design, and study populations in Western developed
countries. Most studies use whole blood sampling (Byrne et al., 2013; Davies et al., 2014;
Córdova-Palomera et al., 2015; Numata et al., 2015; Uddin et al., 2011), while a small
handful examined brain tissue from deceased individuals (Kaut et al., 2015; Nagy et al.,
2015; Sabunciyan et al., 2012). Sample sizes range from N = 12 to 473. The number of
significant hits varies widely based on methodology from zero to 115; there are no
specific genes that stand out as frequent replications. This lack of overlap may be due to
the complexity of the depression phenotype as well as methodological differences in
study design, technology platforms, type and timing of tissue sampling, assessment of
depression symptoms including different measures at different stages in the lifespan, and
small sample sizes.
Almost all epigenome-wide studies utilize convenience sampling of adults, most
often in middle to late adulthood, making it difficult to disentangle DNA methylation
changes as causes or consequences of depression. Only two cross-sectional studies
conducted an EWAS in an adolescent sample (Boström et al., 2017; Dempster et al.,
2014). Dempster and colleagues (2014) utilized 18 pairs of monozygotic twins discordant
for depression and did not find any differentially methylated regions (DMR) that survived
corrections for multiple testing. However, in a recent study, Bostrom and colleagues
(2017) found that hypomethylation of a CpG site located on the promoter region of micro
RNA 4646 (MIR4646) was related to an increased risk of depression. This finding was
replicated in a validation sample and in a sample of post-mortem frontal cortex tissue in
deceased subjects with a history of major depression. Genes related to MIR4646 play a
major role in the conversion of omega-3 fatty acids, which have been previously
associated with MDD (for a meta-analytic review see Lin & Su, 2007).
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There has been one small longitudinal analysis examining DNA methylation in
adolescence (N=23 cases and N=36 controls, Mage = 18.6) that attempted to identify
epigenome-wide associations between changes in depression risk and changes in DNA
methylation levels from baseline to 1 year follow up (Ciuculete et al., 2019). After FDR
correction, no significant CpG probes were identified; however, there were 9 nominally
significant probes. The largest methylation difference was detected at cg24627299 within
the hepatocyte growth factor receptor (MET) gene, a gene involved in sending signals
within cells and in cell growth and survival.
Fetal Programming Studies. There are a handful of longitudinal studies of DNA
methylation assessed at birth predicting outcomes later in childhood that typically focus
on externalizing disorders including ADHD (Neumann et al., 2019; van Mil et al., 2014),
ODD (E. D. Barker et al., 2018), conduct problems (Cecil et al., 2018) and substance use
(Cecil et al., 2016); these studies typically show robust DNA methylation differences.
Although there is evidence that prenatal stress predicts internalizing outcomes later in
childhood, less is known about the role of DNA methylation in this pathway. A small
handful of studies have examined more proximal infant behavioral phenotypes in the
context of prenatal stress and DNA methylation including cortisol reactivity (Oberlander
et al., 2008) and aspects of neurobehavior such as self-regulation, hypotonia, lethargy,
habituation, and reflexes (Appleton et al., 2015; Conradt et al., 2013b; Monk et al., 2016)
but none have assessed more specific depression symptomatology later in life. To our
knowledge, this is the first study (candidate gene or EWAS) to examine DNA
methylation at birth and a depression phenotype later in childhood.
Current Study
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We build upon previous epigenome-wide studies of depression in the following
ways: (1) Studies in behavioral epigenetics continue to operationalize depression as a
categorical construct assessed at a single time point. Researchers typically create two
comparison groups based on a clinically significant cut-off point of a sum score of
symptoms. We were able to utilize repeated measures of depression symptoms from early
to late adolescence to identify groups that are homogenous in terms of their initial levels
of symptomatology at the beginning of adolescence and the slope of their symptoms over
time. In addition to providing novel insights into the biological mechanisms of depression
over time, the ability to reduce heterogeneity in the depression phenotype may boost
power to detect epigenetic changes. (2) We examine depression in early to late
adolescence at a time that is developmentally relevant in understanding the causative
mechanisms in the onset of depression. Most studies examine depression in mid to late
adulthood, where it is unclear whether DNA methylation changes reflect a causal
mechanism or instead represent the “wear and tear” that chronic depression and its
accompanying sequela including substance use and health problems has on the
epigenome throughout the lifespan. (3) The longitudinal nature of this study allows us to
also examine depression through the fetal programming framework where we are able to
examine whether epigenetic changes present at birth can set developmental trajectories
that confer risk for depression later in adolescence. Moreover, the design allows us to test
whether the same genes or genetic networks are implicated in depression at different
sensitive periods potentially pointing to distinct pathways by which epigenetic
modifications at different points in development increase risk for depression. (4) We
utilize the largest sample size in an EWAS of depression to date.
Methods
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Participants
The ARIES subsample of ALSPAC was used. Final analytic samples for analyses
included only participants who had both depression and methylation data available (N =
830 for prenatal analyses and N= 893 for adolescent analyses). Analyses at birth and
adolescence largely included the same participants (90% match across data sets, N = 801
participants present in both sets of analyses). DNA methylation in adolescence was
measured either at age 15 (n = 222, 25% of the participants) or at age 17 (n = 671, 75%
of the participants). See Figure 5 for descriptive flowchart of sample.
Measures
Depression Trajectories. Depression was assessed using The Short Moods and
Feelings Questionnaire (SMFQ; Angold, Costello, Messer, & Pickles, 1995), a 13-item
child self-report questionnaire that enquired about the occurrence of depressive
symptoms over the past 2 weeks. Scores range from 0-26. A cut-off of 11 and above has
been used to describe clinically significant symptoms (Joinson et al., 2012). The SMFQ
has been validated as a tool for assessing depressive symptoms in adolescence (Turner et
al., 2014) and distinguishes children with depression from those who are not depressed in
general population samples (Sharp et al., 2006). Previous studies done with ALSPAC
data have shown that the mean SMFQ score and variability increase from childhood to
adolescence (Niarchou, Zammit, & Lewis, 2015; Sequeira, Lewis, Bonilla, Smith, &
Joinson, 2017). By the age of 18, 8% of the sample meets ICD-10 criteria for depression
(Niarchou et al., 2015). This study uses SMFQ data collected at mean ages 12.5, 13.5, 16,
and 17.5.
DNA Methylation. DNA methylation was assayed according to standard protocol
described in the Introduction to the thesis (p. 19-22). In an attempt to reduce non46

biological differences between probes, samples were functional normalized using 10
principal components derived from control probes using the “meffil” package in R.
Covariates for DNA Methylation at Birth. Research has shown that a number
of prenatal environmental factors impact differential DNA methylation in newborns
including infant birthweight (Filiberto et al., 2011), infant gestational age or pre-term
birth (H. Lee et al., 2012; Schroeder et al., 2011), and maternal age (Adkins et al., 2011).
In addition to these covariates, we also controlled for maternal substance use including
smoking cigarettes, marijuana use, and alcohol use. Mothers were asked about substance
use at different time points throughout pregnancy.
Cigarette Use. Smoking is considered one of the most powerful environmental
modifiers of DNA methylation across the lifespan. Research has shown that mother’s
prenatal smoking has large effects on infant DNA methylation in cord blood (Küpers et
al., 2015; Lee et al., 2015). Mothers were asked how many times per day did they smoke
cigarettes at three time points (first, second, and third trimester). Data from each time
point was entered into the model as a separate continuous covariate.
Alcohol Use. Chronic alcohol use in pregnancy has a number of deleterious
developmental effects on the fetus, often culminating in fetal alcohol syndrome (FAS).
Some research has shown differential methylation profiles in infants who were born with
FAS (Laufer et al., 2015; Portales-Casamar et al., 2016). However, research has shown
that there are no consistent adverse developmental consequences of low to moderate
alcohol use during pregnancy (see for review Henderson, Gray, & Brocklehurst, 2007).
Mothers were asked to rate on a 6-point scale, how often they used alcohol ranging from
“none” to “greater than 9 glasses daily” during the first and third trimesesters of
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pregnancy. Data from each time point was entered into the model as a separate
continuous covariate.
Marijuana Use. To our knowledge there is no research examining the effects of
marijuana use on epigenetic changes in human offspring. However, numerous animal
models have shown that chronic prenatal exposure to cannabinoids triggers epigenetic
changes that have suppressive immunological effects on offspring (see Zumbrun, Sido,
Nagarkatti, & Nagarkatti, 2015 for a review). Therefore, as a precaution, we included
marijuana use as a covariate in our analyses due to its potential influence on
development. Mothers were asked to rate on a 6-point scale, how often they used
marijuana or any cannabis products ranging from “none” to “every day” at the same time
points they were asked about cigarette smoking. Data from each time point was entered
into the model as a separate continuous covariate.
Data were available regarding illicit drug use during pregnancy (e.g. cocaine,
heroin). However, none of the mothers in our analytic sample indicated any illicit drug
use during pregnancy. Tables 4 and 5 show descriptive statistics for EWAS analyses at
birth and in adolescence, respectively broken down by depression trajectories.
Covariates for DNA Methylation in Adolescence
Substance Use. Research has shown a robust link between depression and
substance use in adolescence (Armstrong & Costello, 2002; Kandel et al., 1999).
Research has also shown that chronic substance use is related to individual differences in
DNA methylation patterns (Parira, Laverde, & Agudelo, 2017; Rotter et al., 2013).
Therefore, we included cigarette smoking and marijuana use as covariates. Covariate
time points were matched with available DNA methylation time points. For example,
adolescents with methylation data collected at age 15 had corresponding covariates
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measured at age 14.5 years, while adolescents with DNA methylation data collected at
age 17 had corresponding covariates measured at 16.5 years. At age 14.5 and 16.5,
adolescents were asked about the frequency of their cigarette smoking ranging from “I
have only ever tried smoking cigarettes once or twice” to “I usually smoke one or more
cigarettes every day.” At the same time points, adolescents were asked about the
frequency of their marijuana use similarly ranging from “I have only ever tried cannabis
once or twice” to “I usually use or take cannabis every day.”
Data regarding illicit drug use was available but was focused on whether or not an
adolescent had experimented with drugs and did not reflect problematic or chronic use.
Data regarding alcohol use was only measured at age 14.5 years and not at 16.5 years.
Because the majority of our sample had DNA methylation data at age 17, alcohol use was
not included as a covariate.
Data Analysis Plan
The subsequent three chapters will describe the methods, results, and discussion points
for (1) latent class growth curve modeling of depression trajecotries in MPLUS (2)
epigenome-wide analyses of depression trajectories and gene annotation, and (3) followup regional and gene network analyses.
CHAPTER 6: A Longitudinal Epigenome-wide Analysis of Depression Trajectories
in Adolescence (Part 2)
Latent Class Growth Curve Modeling of Depression Trajectories
Methods
Due to the heterogeneous nature of the course of depression over time, we
utilized a latent class growth curve model in MPLUS to extract homogenous subgroups
of adolescents with distinct developmental trajectories of depressive symptoms. We
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utilized the full ALSPAC sample (N = 15,445) to retain power and controlled for sex. It
is well-known that females are at twice the risk for developing depression compared to
males. Therefore, it is likely that sex has significant effects on the growth factors of the
model including the intercept and slope as well as trajectory classification (i.e.
classification into one trajectory class over another may be due to sex and not depression
score). Only participants who had depression data available from at least one time point
were included in the analysis (N = 8,360). Mplus handles missing data by the standard
approach of Missing At Random (MAR) under Maximum Likelihood (ML). This means
that it uses all the data that is available to estimate the model using full information
maximum likelihood where each parameter is estimated directly without filling in
missing data values for each individual (Muthén & Muthén, 1998). Previous research
deriving depression trajectories from the ALSPAC cohort has demonstrated little
difference on the shape of trajectories, distribution of trajectory membership, or
associations of trajectories with outcomes when comparing individuals with at least 1
measurement of depression symptoms with participants with at least 3 or more measures
(Kwong et al., 2019).
Following guidelines in the field based on simulation studies (Nylund et al.,
2007), number of classes were determined by the following fit indices: Lo-MendellRubin adjusted likelihood ratio test (LMR-LRT) and the bootstrap likelihood ratio test
(BLRT), where significant p-values prompt the rejection of the k-1 model in favor of the
K-class model. Other considerations also included model convergence, lower Bayesian
Information Criterion values, higher entropy values (near 1.0), no less than 1-2% of
participants in a class, and higher posterior probabilities (values > 70% indicating good
model fit) (Jung & Wickrama, 2008).
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Extracting Depression Class Trajectories
Class solutions were examined in a sequential order starting from a two-class
structure. The two-class model indicated a “low” (N = 7087; 85%) and a “high” (N =
1273; 15%) depression group (LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.83;
BIC=296434.645). Because significant LMR-LRT and BLRT values prompt the rejection
of the k-1 model in favor of the k model, this meant that a two-class solution was a better
model fit than a one-class solution. The three-class model indicated a “low” (N = 6732;
77%), “increasing” (N = 949; 14%), and “moderate/decreasing” (N = 679; 9%) group
(LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.80; BIC = 248937.648). Again,
significant p-values indicated that a three-class solution was a better model fit that a twoclass solution. The four-class model yielded a “low” (N = 6350; 76%), “increasing” (N =
775; 9%), “moderate/decreasing” (N = 978; 12%), and always high (N = “257”; 3%)
group (LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.79; BIC = 294141.890).
Although the four-class model converged and p-values were significant, the results were
unreliable due to solutions being local maxima that did not resolve with increased
random starts. In MPLUS, the estimation algorithm attempts to converge on the globally
best solution with the largest loglikelihood – one set of parameter values. However,
sometimes it converges on a local maximum solution, which is the best solution around
the parameter, but not the best one. This coupled with increased BIC value, decreased
entropy, only 3% of participants in one class, and posterior probabilities dropping to
70%, the three-class solution was chosen as the most reliable model fit for the analyses.
Depression trajectories were classified on the entire ALSPAC sample. See Figure 6 for
visual representation of depression trajectories. When applied to the ARIES DNA
methylation subset, the final analytic sample retained similar class proportions. In the
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birth EWAS, 80% of participants were classified in the low trajectory (n = 662), 11% in
the increasing trajectory (n = 94), and 9% in the moderate/decreasing trajectory (n = 74).
In the adolescent EWAS, 80% of participants were classified in the low trajectory (n =
720), 11% in the increasing trajectory (n = 77), and 9% in the moderate/decreasing
trajectory (n = 64).
There is a vast literature examining longitudinal depression trajectories in
adolescence. Using various trajectory modeling techniques, the number of unique class
trajectories range from 3 to 6 with usually a consistent “low” group and variations of
“increasing”, “high”, “moderate”, and “decreasing” groups (for a review see Schubert et
al., 2017). In a recent meta-analysis examining 20 longitudinal studies published in the
past 20 years, a random pooled effect estimate identified a consistent “no or low” group
(56% of the sampled study populations), a consistent “moderate” group (26%) and a
variations of “high”, “increasing” or “decreasing” groups (12%) (Shore et al., 2017).
Regarding the ALSPAC cohort specifically, the number and types of depression class
trajectories has also varied. Using 7543 adolescents with data between 10.5 years and
18.5 years of age, 3 trajectory classes were identified using a dichotomous depression
score (i.e. using the SMFQ clinical cut-point of 11): “persistently low” (74%), “lateradolescent onset” or “increasing” group (17%) and an “early-adolescence onset” or
“stably moderate/high” group (9%) (Frances Rice et al., 2002). These trajectory groups
closely match our classifications. On the other hand, using a sample of 3525 ALSPAC
individuals with measurements extending into adulthood (i.e. mean age 24), 5 trajectories
were identified: “low” (71%), “early-adult-onset” (11%), individuals who started with
low depression symptoms that increased during adolescence and young adulthood,
“adolescent-limited” (9%), individuals who experienced elevated levels of depression
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symptoms only during adolescence, “childhood-limited” (6%), individuals who started
with elevated levels of depression symptoms in childhood that decreased. and
“childhood-persistent” (3%) individuals with moderate levels of depression symptoms
that continued to increase and stay high during adolescence and into young adulthood
(Kwong et al., 2019). Although there are differences likely due to the result of extending
measurements well into young adulthood, Kwong and colleagues’ results are still broadly
comparable to the three-class solutions.
Describing the Depression Class Trajectories.
Descriptive statistics for the depression trajectories for the analytic sample for the
birth EWAS and for the adolescence EWAS sample were near identical and are discussed
here more broadly. See Tables 4 and 5 for more specific descriptive statistics of
depression trajectories separated by EWAS analytic sample. The majority of the
increasing trajectory (70%) and the moderate/decreasing trajectory (around 65%) was
made up of females. Females made up less than half of the low trajectory group (around
48%). For the low depression trajectory, mean depression scores (i.e. SMFQ; total 26,
clinical cut-off 11) stayed in the 2-6 range across all 4 times points. For the increasing
trajectory, mean depression scores started low (M = ~ 5), increased by age 13 (M = ~10),
and continued to increase into late adolescence (M= ~15). For the moderate trajectory,
mean depression scores were clinically significant at age 12 (M= ~13) and slightly
decreased in later adolescence to be below the clinical cut-point (M= ~9).
An ANOVA with Tukey HSD was used to assess any potential mean differences
in covariates across the three trajectory groups. For the birth analytic sample, the three
trajectories did not significantly differ on most covariates including gestation length,
maternal age at birth, birth weight, mother’s alcohol use and mother’s smoking during
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pregnancy. Individuals in the increasing trajectory had mothers with increased use of
marijuana, though this was only a significant difference compared to the low group and
only in the 3rd trimester.
For the adolescent analytic sample, individuals in the increasing and moderate
trajectories had significantly higher levels of adolescent cigarette smoking compared to
the low group. Individuals in the increasing and moderate trajectories had higher levels of
adolescent marijuana use compared with the low group, though differences were only
significant in the moderate vs. low group. Results regarding cigarette smoking are
consistent with a robust literature describing increased smoking by depressed adolescents
and adults (see reviews e.g. Chaiton et al., 2009; Fluharty et al., 2017; Lee & Pausova,
2013; Weinberger et al., 2017) with less robust results describing increased marijuana use
(Brook et al., 2011; Passarotti et al., 2015)
CHAPTER 7: A Longitudinal Epigenome-wide Analysis of Depression Trajectories
in Adolescence (Part 3)
Epigenome-Wide Analyses (EWAS) of Depression Trajectories
EWAS Methods
For our EWAS analyses, we were particularly interested in the increasing trajectory as
those individuals show a dramatic increase in depression symptoms from very low during
pre-adolescence to more severe levels by age 18. In order to test whether youth whose
symptoms of depression increased across adolescence were biologically distinct from
those with stable low or moderate symptoms, we compared patterns of DNA methylation
(1) at birth and (2) in adolescence for the increasing versus low trajectories and for the
increasing versus moderate trajectories. In order to increase power in our EWAS
analyses, we also combined the increasing and moderate/decreasing trajectories to form a
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high group and compared patterns of DNA methylation to the low group. Thus, we
conducted 6 EWAS in total. In addition, as supplementary analyses, we also ran a more
“traditional” case-control design EWAS using depression at a fixed time point (age 17.5).
We used the clinically significant SMFQ cut point of 11 to categorize participants into
depressed (N = 173) and non-depressed groups (N = 567) and compared patterns of DNA
methylation at birth and in adolescence.
Due to the large size and subsequent processing burden of the data (i.e. 485,000
data points per individual for 1,000 individuals across 2 time points), initial data cleaning
and variable derivation was conducted using the University of Pennsylvania School of
Arts and Sciences high performance computing cluster in which “jobs” were submitted
using Linux code to run on multiple computers simultaneously. Once data were cleaned
and processed, EWAS analyses were able to run on a personal computer. EWAS analyses
were performed using a general linear model using the ‘CpG assoc’ package
implemented in R. All analyses controlled for sex, cell type proportion (as described in
the Introduction), and sample ID for additional batch effect controls. As described in the
Introduction, probes known to be polymorphic or cross-reactive were removed prior to
analysis. In addition, participants with non-Caucasian or missing ethnicity (based on selfreports, n = 28) were removed prior to the analysis to control for race/ethnicity effects on
DNA methylation. Analyses using DNA methylation at birth included the following
covariates that potentially have effects on DNA methylation levels in cord blood: infant
birthweight, mother’s age, infant gestation length, mother’s alcohol, marijuana, and
cigarette use during pregnancy. Analyses using DNA methylation in adolescence
included the following covariates: adolescent marijuana and cigarette use.
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An EWAS essentially entails conducting hundreds of thousands of linear
regressions at one time. If 485,000 CpG sites are being interrogated, around 1/20 or
20,000 can be false positives (i.e. significant hits that are significant by chance and not
due to underlying biological differences) due to Type 1 error if using traditional α = 0.05
thresholds. The multiple comparison problem in epigenome-wide analyses is most often
addressed through Benjamini & Hochberg’s (1995) false discovery rate (FDR)
correction, which estimates and controls for the proportion of false positives in an
analysis. We utilized the FDR correction in all our analyses (q <.05). Because DNA
methylation analyses yield very small effect sizes, statistical power to detect those small
effects is always a concern. It is likely that low statistical power results in some number
of relevant CpG hits that do not cross the threshold of significance after FDR correction.
Therefore, many researchers report hits that are approaching significance. We used the
most liberal genome-wide threshold proposed in the literature (

) to identify hits

we label as nominal (Rakyan et al., 2011). Hits below this liberal threshold are less likely
to be true hits not detected due to power concerns. Once FDR-corrected differentially
methylated CpG sites or “hits” are identified, individual linear regressions are performed
comparing mean methylation levels on that CpG site between trajectory groups to extract
more specific regression statistics including standardized betas, standard error, and
adjusted R values. CpG hits are then mapped to their respective gene sites through
extensive probe annotation available from Illumina that includes probe location within
genes (annotated by University of California, Santa Cruz (UCSC) Genome Browser
(http://genome.ucsc.edu; UCSC Genome Bio- informatics, Santa Cruz, CA, USA), CpG
islands and shores, and regulatory features.
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As with genome-wide association studies, epigenome-wide statistical inflation
resulting in increased rates of false positive is also of concern. High genomic inflation is
thought to be caused by population stratification, technical batch effects, sample quality,
and unknown relatedness between samples (Devlin & Roeder, 1999). Usually, the
inflation is quantified using the genomic inflation factor (λ), which is defined as the ratio
of the median of the empirically observed distribution of the test statistic to the expected
median. Therefore, the lambda is used to calculate the deviation of a distribution of
residuals from a null distribution. A genomic inflation factor of 1.0 or lower reflects no
evidence of inflation while increasing values reflect inflation. Researchers also often
visually inspect quantile-quantile (QQ) plots that are able to graph the deviations of the
observed distribution from the expected null distribution.
Results: DNA Methylation at Birth.
High Versus Low Trajectories. At birth, no probes were differentially
methylated
between the high (increasing + moderate) versus low trajectories after FDR correction,
nor were any probes approaching significance.
Increasing Versus Low Trajectories. At birth, no probes were differentially
methylated between the increasing and low trajectories after FDR correction when
controlling for smoking, alcohol, and marijuana use during pregnancy as well as birth
characteristics, sex, cell type, and plate number. One probe, cg08214693 was
approaching significance but still did not meet nominal significance cut-offs.
Cg08214693 was hypomethylated in the increasing trajectory and was annotated to
SCRIB (scribbled planar cell polarity protein). See Table 6 for more details. Absolute
mean percentage methylation between the increasing and low trajectory groups was
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1.3%. Inspection of the QQ plot (Supplementary Figure 4) and a lambda statistic of 0.79
provided little evidence of inflation of test statistics. See Figure 7 for manhattan plot of
EWAS.
Increasing Versus Moderate Trajectories. At birth, no probes were
differentially methylated between the increasing versus moderate trajectories after FDR
correction, nor were any probes approaching significance.
Supplementary Analyses. When examining depression at a single time point at
age 17.5, there were no probes differentially methylated between the depressed and nondepressed groups after FDR correction, nor were any probes approaching significance.
Results: DNA Methylation at Adolescence
High Versus Low Trajectories. In adolescence, one probe was differentially
methylated between the high (increasing + moderate) and low trajectories after FDR
correction when controlling for covariates (See Table 7 for more details). Cg06758781
was hypomethylated in the high group (q = 0.02) and was annotated to AACS (Activates
acetoacetate to acetoacetyl-CoA). Inspection of the QQ plot (Supplementary Figure 5)
and a lambda statistic of 0.856 provided little evidence of inflation of test statistics. See
Figure 8 for Manhattan graph of results.
Increasing Versus Low Trajectories. In adolescence, one probe was
differentially methylated between the increasing and low trajectories after FDR
correction when controlling for smoking, marijuana use, cell type, sex, and plate number
while 6 probes were approaching significance (See Table 8 for more details).
Cg06460328 was hypermethylated in the increasing group (q = 0.030) and was annotated
to CBFA2T3 (CBFA2/RUNX1 translocation partner 3). Absolute mean percentage
methylation between the increasing and low trajectory groups was 2%. All 6 nominal hits
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were also hypermethylated in the increasing group with methylation differences ranging
from 1% - 2.5%. See Table 8 for further details. Inspection of the QQ plots
(Supplementary Figure 6) and lambda statistic of 1.09 provided evidence of some mild
inflation of test statistics. See Figure 9 for Manhattan graph of results.
Increasing Versus Moderate Trajectories. In adolescence, no probes were
differentially methylated between the increasing versus moderate trajectories after FDR
correction.
Supplementary Analyses. When examining depression at a single time point at
age 17.5, there were no probes differentially methylated between the depressed and nondepressed groups after FDR correction, nor were any probes approaching significance.
Follow-up Regional Analyses
Data Analysis Plan
EWAS studies typically interrogate DNA methylation at the individual CpG level.
Although this is very informative, it does not take into account the broader context of the
DNA methylation status of its neighboring CpG sites, as sometimes a gene is not turned
on and off by the action of a single CpG site but rather a cluster of CpG sites in close
proximity to one another through co-methylation. Results have shown moderate levels of
correlations (0.25-0.40) in proximal CpG sites up to a distance of 1kb apart and no
significant correlations once inter-pair distances reach around 2kb (Saffari et al., 2018).
Therefore, researchers have started to additionally interrogate differentially
methylated regions (DMRs) as complementary analyses to EWAS. This region-based
approach is statistically more powerful with a lower rate of false positive findings and has
the potential to be more biologically informative than individual CpGs. Many
bioinformatic packages to interrogate DMRs are available. We utilized the DMRcate
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package in R (Peters et al., 2015), which identifies and ranks the most differentially
methylated regions across the genome. It is a data-driven agnostic approach that does not
favor known annotated genomic regions (i.e. known CpG islands) and has the ability to
assess all 450k probes.
First, estimates of differential methylation at individual CpG sites are derived
using the limma package in R (this package is similar to CpGassoc used for the single
CpG site EWAS). Identical covariates to the EWAS were used in all regional analyses.
The corresponding t-statistic obtained with each probe’s beta value is utilized in the
DMR-finding function to which a Gaussian kernel smoothing method is applied. A kernel
smoother is a statistical technique used to estimate the real value of a function as the
weighted average of neighboring observed data. The weight is defined by the kernel,
meaning that closer points are given higher weights. A Gaussian kernel is a kernel with
the shape of a Gaussian or normal distribution curve. The length of the nucleotide region
can be user specific, though the authors of the package suggest a bandwidth of 1000
nucleotides (lambda = 1000) and a scaling factor of 2 (C = 2; at least 2 CpG sites in a
region). Significant p-values were again FDR-corrected for multiple testing. Data output
consists of significant regions ranked by their corresponding p-values as well as genomic
coordinates and gene associations.
Results: Regional Analyses with DNA Methylation at Birth
Using DNA methylation analysed at birth, no regions were differentially
methylated in either high (moderate + high) versus low, increasing versus low, or
increasing versus moderate analyses.
Results: Regional Analyses with DNA Methylation in Adolescence
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High Versus Low Trajectories. In adolescence, regional analyses identified 1
differentially methylated region using the fully adjusted model (q <0.05). See Table 9.
This region was mapped to the Small Nucleolar RNA (SnoRNA) family of non-coding
RNAs.
Increasing Versus Low trajectories. In adolescence, regional analyses identified
3 differentially methylated regions using the fully adjusted model (q <0.05). See Table
10. These regions were mapped to Zinc Finger and BTB Domain Containing 44
(ZBTB44), Bladder Cancer-Associate Protein (BLCAP), and the Small Nucleolar RNA
(SnoRNA) family of non-coding RNAs.
Increasing Versus Moderate Trajectories. No regions were differentially
methylated between the increasing and moderate trajectories.
Discussion of Genes Implicated in EWAS and Regional Analyses
Utilizing the ALSPAC longitudinal cohort to extract latent class trajectories of
depression symptoms, we conducted EWAS analyses using DNA methylation obtained at
birth and during mid-adolescence. To examine potential fetal programming effects, we
assessed whether DNA methylation patterns present at birth differentiated the increasing
trajectory class compared to the low and moderate/decreasing trajectory classes. In our
birth EWAS analyses, the closest hit to significance (q = .074) was annotated to the
SCRIB gene and hypomethylated in the increasing group compared to the low depression
group. The SCRIB gene is a scaffold protein that is part of a pathway of genes called the
Scribble complex that is involved in cell migration, cell polarity (i.e. spatial differences in
shape, structure, and function of a cell), and cell proliferation in epithelial cells (Anastas
et al., 2012). Loss of cell polarity is a hallmark of epithelial cancers and therefore
regulators of polarity are hypothesized to play a major role in suppression of
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tumorigenesis. Recent studies have shown that increased expression on SCRIB is related
to adverse clinical outcomes in breast cancer and that reducing its expression reduced the
growth of human breast cancer cells (Anastas et al., 2012). A recent EWAS of depression
symptomatology measured in an elderly cohort of 742 monozygotic Danish twins, also
identified 3 CpG sites mapped to the SCRIB gene in regional analyses that were
differentially methylated in the depressed group (Starnawska et al., 2019). Interestingly,
the SCRIB gene was not in our top 50 hits in our EWAS using DNA methylation in
adolescence. Results of this hit are presented for informational purposes. However, this
CpG site did not reach even more liberal nominal level of significance and therefore
should be interpreted with caution.
Although research on externalizing disorders such as ADHD, conduct problems,
and ODD (Barker et al., 2018; Cecil et al., 2018; Neumann et al., 2019; van Mil et al.,
2014) have shown robust association with DNA methylation at birth, much less is known
about fetal programming effects of internalizing disorders To our knowledge, this was
the first study to assess whether DNA methylation profiles at birth can predict depression
outcomes later in development. Interestingly, our analyses did not show any potential
fetal programming effects. It is possible that prenatal risks may be embedded more
broadly as traits and predispositions (i.e. emotional reactivity) that may be exacerbated by
the psychological, behavioral, and physiological consequences of the trait including
emotion dysregulation, difficulty in social relationships, and unhealthy coping behaviors
throughout childhood. This can culminate in development of depression in adolescence
triggered by more specific developmental demands during this sensitive period, which
includes a multitude of neural and hormonal changes. This is supported by the fact DNA
methylation studies examining prenatal stress and more trait-like features in infancy find
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robust results (Appleton et al., 2015; Conradt et al., 2013b; Monk et al., 2016), and the
fact that the prevalence rates of depression in childhood is rare and increases dramatically
in adolescence (Hankin et al., 2015b). In addition, disorders like ADHD and ODD
manifest much earlier in childhood, while the incubation period for depression is much
longer, and therefore may include more downstream cascading effects that are
unmeasured. More research is needed to elucidate the potential fetal programming effects
that underlie internalizing disorders via DNA methylation mechanisms.
Given the dearth of EWAS studies of depression occurring in adolescence, we
also examined whether DNA methylation in mid-adolescence predicted depression
trajectory groups. When collapsing the two clinically significant depression groups
(increasing and moderate/decreasing) into one “high” category and comparing it to the
low group for a more powerful analysis, one CpG hit annotated to the AACS gene was
significant even after correction for multiple testing and hypermethylated in the “high”
group. No other depression EWAS has identified this gene. AACS is hypothesized to be
involved in utilizing ketone body (i.e. energy source that is mainly produced in the liver)
for fatty acid-synthesis during adipose tissue development (Hasegawa et al., 2012). Highfat diet obesity has been shown to induce unusual metabolism of ketone bodies through
inflammatory mechanisms (Puchalska & Crawford, 2017). Research on the expression of
AACS is scant and exclusively has been assessed in animal models. Interestingly, one
study has shown increased expression of AACS as a result of inflammatory mechanisms
due to a high fat diet (Yamasaki et al., 2016)
Our results did not show DNA methylation differences between the increasing
and moderate trajectory. There was one CpG site that was nominally significant but not
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annotated to a specific gene and therefore the function of this differential methylation in
largely unknown.
When comparing the increasing trajectory group to the low group, one CpG hit
annotated to the CBFA2T3 gene was significant even after correction for multiple testing
and was hypermethylated in the increasing group. No other depression EWAS has
identified this gene. The CBFA2T3 gene is responsible for transcription repression.
Research has shown that the expression of CBFA2T3 was significantly reduced in breast
cancer cell lines and breast tumors and CBFA2T3 has emerged as a candidate gene of
breast cancer tumor suppression (Kochetkova et al., 2002; Kumar et al., 2006).
Additionally, there were 6 CpG hits that were nominally significant (p < 1 x 106)
that were annotated to 6 genes: LRTOMT (Leucine Rich Transmembrane And OMethyltransferase Domain Containing), NUMA1 (Nuclear Mitotic Apparatus Protein 1),
LDB1 (LIM Domain Binding 1), USF2 (Upstream Transcription Factor 2, C-Fos
Interacting), HEY2 (Hes Related Family BHLH Transcription Factor With YRPW Motif
2), and BLCAP (BLCAP Apoptosis Inducing Factor). Not much is known about the
specific biological mechanism of LRTOMT except that it is an O - methyl transferase
heavily implicated in the morphology and physiology of ear development and its
mutation has been consistently studied as leading to autosomal recessive non-syndromic
hearing loss (i.e. non-specific genetic hearing loss) (Charif et al., 2012; Taghizadeh et al.,
2013; Vanwesemael et al., 2011). NUMA1 is also an understudied gene that codes for the
spindle protein NuMA; spindle fibers form a protein structure that divides the genetic
material in a cell (Quintyne et al., 2005). Only one study has assessed expression of
NUMA1 directly and linked increased expression to epithelial ovarian cancer due to its
role in aneuploidy (i.e. presence of an abnormal number of chromosomes in a cell, as
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often seen in cancer cells) (Brüning-Richardson et al., 2012). However, more research
needs to be done to elucidate whether NUMA1 is consistently involved in carcinogenesis.
LDB1 is a transcription cofactor (i.e. modulates the effects of transcription factors
by recruiting other proteins for binding). It is part of a complex that maintains the
function of erythroid cells (i.e. most common blood cell and principal means of
delivering oxygen to the body tissues via blood flow through the circulatory system)
through transcription activation (Matthews & Visvader, 2003). Due to its role in
modulation of transcription factors it has been studied in the context of cancer
progression. Studies have shown that overexpression of LDB1 is associated with negative
prognosis factors in colorectal, head, and neck cancer (García et al., 2016; Simonik et al.,
2016).
USF2 (and its counterpart USF1) are transcription factors (i.e. proteins that bind
to the DNA sequences of their target genes and participate in the regulation of a large
number of genes) and part of the basic helix-loop-helix (bHLH) class. USF2 in particular
appears to be crucial for embryonic development, brain function, metabolism, iron
homeostasis and fertility while USF1 has more specific roles in metabolism and immune
system functioning (Horbach et al., 2015). Recent research suggests that deregulation of
transcription factors can cause tissue damage and suggests a major role for transcription
factors in the inappropriate growth of cancer cells. In fact, the USF genes seem to exhibit
a tissue protective and tumor suppressive function in several cancer types (Horbach et al.,
2015). Most consistently, downregulation of USF2 has been linked to the proliferation of
breast and prostate cancer (Chen et al., 2006; Ismail et al., 1999; Kivinen et al., 2004; Tan
et al., 2019). Similarly to USF2, HEY2 is a bHLH transcription factor, involved primarily
in the regulation of cell differentiation of the cardiovascular system and the heart itself
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(Iso et al., 2002). Increased expression of HEY2 has been linked to the progression of
prostate, liver, and pancreatic cancer (Cavard et al., 2009; Tradonsky et al., 2012; Wu et
al., 2016). One
EWAS comparing 20 medication free patients with MDD and 19 control subjects (Mage
= 44) found 363 differentially methylated CpG sites after FDR correction for multiple
testing, one of which was annotated to HEY2. However, it is important to note that the
study did not correct for cigarette smoking and most importantly did not control for celltype heterogeneity which greatly limits our ability to identify this as a true replication.
Finally, the BLCAP gene encodes a protein that reduces cell growth by
stimulating apoptosis (i.e. cell death) and is hypothesized to play a major role in the
regulation of tumor cell proliferation and survival. Studies have shown that decreased
expression of the BLCAP gene was associated with the progression of cervical, renal,
bladder, and tongue cancer tissue, and conversely increased expression in breast cancer
tissues (Gromova et al., 2012). This gene was also implicated in regional analyses (6
CpG sites) comparing the increasing to low trajectory group suggesting that it may be the
most consistent finding in our EWAS though it only reached nominal significance in the
single CpG site analysis.
In addition to BLCAP, two other differentially methylated regions were identified
in regional analyses. Two CpG hits were identified on the ZBTB44 gene. Not much is
known about the ZBTB44 gene, except that it is primarily involved in transcription
regulation and nucleic acid binding (www.genecards.org). Four CpG sites were identified
in a region composed of several small nucleolar RNAs (snoRNAs). snoRNAs are a type
of non-coding RNA (i.e. RNA transcripts that never get translated to protein and
consequently are never expressed). For a long time, non-coding RNA have been
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considered as cellular housekeeping maintenance molecules or “junk DNA” due to their
non-coding nature. However, recent research has demonstrated that in addition to DNA
methylation and histone modification, non-coding RNAs are essential mechanisms of
epigenetic changes and function as post-transcriptional modulators of gene expression,
especially during development and disease progression (Peschansky & Wahlestedt, 2014;
Watson et al., 2019; Wei et al., 2016). snoRNAs are crucial for ribosomal RNA (rRNA)
maturation and functionality (Gaviraghi et al., 2019). Because hyperactive ribosomal
biogenesis is widely observed in cancer, an increasing body of work has linked increased
expression of snoRNAs to renal, colorectal, lung, prostate, and breast cancer (Baral et al.,
2018; Gao et al., 2015; Mannoor et al., 2014; Martens-Uzunova et al., 2015; Okugawa et
al., 2017; su et al., 2013).
CHAPTER 8: A Longitudinal Epigenome-wide Analysis of Depression Trajectories
in Adolescence (Part 4)
Gene Networks and Functional Enrichment Analyses
Methods
After decades of genomic research, it is now best understood that genes often act
in concert with each other rather than in isolation. It has been increasingly apparent that
the function of a single gene cannot explain genetic liability for phenotypically complex
biomedical and psychological disorders that are most likely the result of polygenic
interactions. A list of differentially methylated genes or regions, although informative,
does not describe how genes may be acting in unison with each other and other
unidentified genes to confer risk. To assess whether the genes identified in our analyses
are related to one another, we inputted them in a bioinformatic webserver called
GeneMANIA (http://www. genemania.org). GeneMANIA mines all publicly available
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biological datasets of all mapped genes in the human genome to create genetic networks.
Researchers can input a list of genes into the server to examine any possible connections
between genes using this comprehensive literature review. Gene networks are compiled
based on several categories including: (1) co-expression; genes are linked if their
expression levels are similar across conditions in gene expression studies, (2) physical
interaction; genes are linked if their proteins are known to physically interact, (3) gene
interaction; genes are linked if the expression of one gene depends on the
presence/absence of another, (4) shared protein domains; genes are linked if they code for
the same protein domain, (5) co-localization; genes are linked if they are both expressed
in the same tissue or if their gene products are both identified in the same cellular
location, (6) pathways; genes are linked if they participate in the same reaction within a
pathway, and finally (7) predicted; genes are linked if they have similar functional
mechanisms. Once a list of genes is inputted into the server, a network is created based
on those seven categories. The weighting of connections between genes is chosen
automatically using linear regression to make genes on the inputted list interact as much
as possible with each other, and as little as possible with genes not in the inputted list.
The network weighting prioritizes gene-ontology, where genes are connected based on
similar biological functions. For more detailed description of network bioinformatics see
Mostafavi et al., 2008 and Warde-Farley et al., 2010.
In order to better understand the underlying biological processes of the gene
network, GeneMANIA also provides functional enrichment analyses using Gene
Ontology (GO) categories. Similarly, GeneMANIA mines the GO database, which is a
bioinformatics initiative to categorize a vocabulary of known genes and their products
into an organized graph structure describing what is known about the biological function
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of known genes. GeneMANIA compares the functional profile (i.e. biological pathway
describing the cellular or physiological role) of the inputted gene set to the functional
profiles described by GO to examine whether the network is significantly enriched for
particular functions. Functional enrichment analyses also use the FDR (q < .05)
correction for multiple testing. GO analyses provide the number of genes in the network
that are implicated in a biological process out of the total number of genes identified in
that process in the literature (i.e. coverage).
The comparison of DNA methylation values in adolescence in the increasing
versus low trajectories produced multiple hits that were annotated to multiple genes (1
FDR corrected significant, 6 nominally significant). We ran gene network and functional
enrichment analyses using genes obtained from these comparisons. snoRNAs are not
genes and therefore were not inputted in the analysis. In exploratory analyses, we wanted
to examine the addition of AACS, a significant hit in the combined “high” versus low
trajectory groups to assess whether it is biologically connected to those genes annotated
in the increasing versus low trajectory group analyses.
Results: Description of the Gene Network
Results of inputting annotated genes into the network analysis showed that rather
than acting in isolation, these genes form a compact cluster network based on known
genetic and physical interactions, shared pathways and protein domains as well as protein
co-expression data. See Figure 10 for visual representation of the gene network. In gene
ontology analyses, the most enriched gene ontology biological functions were related to
sequencing specific DNA binding, bhlh transcription factor binding, and cardiac
development, which corresponds to our literature review of annotated genes. See Table
11 for comprehensive gene ontology descriptions.
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Interestingly, ZBTB47, a gene identified in regional analysis but not the EWAS,
emerged as part of this network though a physical reaction with CBFA2T3. LRTOMT
and NUMA1 were only tangentially related to the network while CBFA2T3, HEY2,
USF2, BLCAP, and LDB1 formed a tighter “cancer gene” cluster. This makes sense as
the biological function of LRTOMT and NUMA1 is still largely unknown. Because
network analyses use existing data to create connections between genes, this does not
necessarily mean that LRTOMT and NUMA1 are unrelated to this cancer network, but
rather more research is necessary to elucidate their function. LRTOMT and NUMA1
were related through co-expression which is consistent with our data as a single CpG hit
was annotated to both genes suggesting they are in close proximity. They are connected
to the network through NUMA1 and LDB1 co-expression, which suggests that they are
potentially biologically relevant to the cancer network. Interestingly CBFA2T3, the only
FDR corrected significant hit, appeared to be central to the 5-gene cancer network and
was connected to USF2, BLCAP, LDB1 through predicted connections. HEY2 is
connected to the network through genetic interactions with BLCAP and USF2, which
makes sense as HEY2 and USF2 both regulate transcription factors.
In exploratory analysis, we assessed the role of AACS, the FDR corrected
significant hit from analyses comparing the combined “high” group to the low trajectory
group, in the gene network. AACS did not appear to be relevant to the cancer gene
network and was only related to CBFA2T3 through a small genetic interaction (See
Figure 11). The fact that AACS was not part of the cancer gene network associated with
the increasing trajectory could suggest that epigenetic correlates of depression that
increases throughout adolescence are distinct from epigenetic correlates of symptoms of
depression that are moderately high throughout adolescence (as seen in the combined
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increasing and moderate/decreasing groups). On the other hand, there is much less
research on the biological function of AACS compared to other genes in the network and
AACS may be more centrally implicated than these analyses show.
Broader Discussion of EWAS, Regional, and Gene Network Analyses
Overall, our results demonstrated a link between genes implicated in cancer
genesis and progression and individuals who demonstrated increasing levels of
depression symptoms as they progressed through adolescence. The prevalence of
depression in patients with various types of cancer exceeds that observed in the general
population and is associated with a poorer prognosis and higher mortality rate Pasquini &
Biondi, 2007). This of course makes intuitive sense; individuals faced with a lifethreatening illness and painful treatment would be more likely to develop depression as a
result. However, there is a body of research that suggests that increased depression
prevalence is not solely a reaction to the socioemotional and physical stress after a cancer
diagnosis and posits that there may be a bi-directional relationship between depression
and cancer with common underlying pathophysiology.
Whether depression earlier in life can be conceptualized as a risk factor for
developing cancer later on has long been debated. Several large-scale longitudinal
epidemiologic studies have reported significant associations between depression
symptoms and subsequent development of cancer (Dalton et al., 2002; Penninx et al.,
1998), and some have not (Kaplan & Reynolds, 1988; Zonderman et al., 1989). A metaanalysis using eight longitudinal, population-based studies found a small but significant
increased risk for cancer among depressed individuals (relative risk = 1.19) (Oerlemans
et al., 2007). The most dominant theory of shared underlying pathophysiology is chronic
inflammation, followed by lesser studied hypotheses of malfunctions in DNA repair.
71

Chronic inflammation propagates increased wear and tear on several biological
systems in the body impairing their functions. In terms of cancer, impaired functioning of
immune cells, most specifically, natural killer (NK) cells creates a immunosuppressive
environment that promotes tumor growth; it has now been evident that an inflammatory
microenvironment is an essential component of all types of tumors (Baniyash et al., 2014;
Grivennikov et al., 2010). Because pro-inflammatory responses over-activate the HPA,
the main mechanism through which cortisol shuts down and inflammatory response,
chronic inflammation has been widely studied as both a result of and precursor to
depression (Miller et al., 2009; Moriarity et al., 2020; Raison & Miller, 2011, 2013; Su,
2012). For example, one meta-analysis found that chronic inflammation preceded the
development of depression even after controlling for a wide range of factors associated
with risk for depression (Valkanova et al., 2013).
It has also been hypothesized that psychosocial stress may have a negative impact
on DNA repair and cell apoptosis which leads to the initiation and production of
abnormal cells, a primary drive of induction of tumor growth and spread (Kiecolt-Glaser
et al., 2002). Stress may decrease the ability of DNA repair enzymes, like
methyltransferase, in carrying out maintenance tasks of tumor suppression.
Our pattern of results potentially supports both of these two theorized biological
mechanisms in different ways. The implication of the AACS gene (with a theorized
critical function in adipose tissue development and consequently obesity) when
comparing individuals with any depression in adolescence compared to individuals with
none suggests that underlying inflammatory mechanisms may differentiate the two
groups broadly. This is supported by a vast literature demonstrating the link between
obesity and depression (for several reviews and meta-analyses see: (Atlantis & Baker,
72

2008; Blaine, 2008; de Wit et al., 2010; Luppino et al., 2010). This pattern of results may
be due to the addition of the moderate/decreasing group whose sustained high levels of
depression even pre-adolescence may better predict or reflect more chronic activation of
the immune system. However, it is important to note that no other genes directly related
to the immune system were implicated suggesting more research needs to be done on the
function of AACS in the context of depression.
When examining the increasing group specifically, no genes directly implicated in
inflammatory processes were identified and instead a cluster of genes heavily implicated
in cancer genesis emerged. Many of the biological function of those genes were DNA
repair and apoptosis and several have been identified as tumor suppressing genes.
However, these results should not serve as a definite evidence for the implication of
cancer related processes underlying the development of depression. The relationships
between inflammation, DNA repair processes, depression, and cancer are likely to be
infinitely complex as both disorders involve the maladaptive disruption of multiple
biological systems and can reflect a wide range of risk factors. In addition, our analyses
used peripheral blood to obtain DNA methylation levels and most studies assessing
expression of our identified genes used target tissues (colon, pancreas, breast). DNA
methylation patterns are tissue-specific (see broader discussion on page 78) and therefore
we cannot make definitive conclusions on the concordance of DNA methylation and
expression of these genes in the blood versus in target tissue during tumor growth.
However, based on review of gene databases (e.g. genecards), all genes annotated in our
analyses are as expressed in the blood as in other tissues and are hypothesized to have
immune system functioning roles. Most importantly, gene annotations are only as
comprehensive as the research that informs them. Cancer research dominates the research
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on the functional role of thousands of genes including the ones identified in our analyses.
It is possible that annotated genes have other functions that many be related to
psychological phenotypes in different ways. More research on the functional role of
genes beyond the context of cancer is necessary for more comprehensive understanding
of novel hits in EWAS.
Limitations
There are several additional limitations of the EWAS design that should be noted.
EWAS is frequently underpowered due to a combination of very small effect sizes (see
more in-depth discussion on page 80), punitive multiple test corrections, and small
sample sizes due to data availability and the cost of microarray assays. No formal power
analyses for EWAS exist, however, some studies have tried to estimate sufficient sample
size for adequate power using data stimulations. Tsai and Bell (2015) found that in a
case-control design, N = 1,000 (or 500 pairs) was necessary to detect DNA methylation
differences between 0-5% in terms of genome-wide significance at 80% power; N = 200
was necessary in monozygotic twin designs. Our sample size is one of the largest seen in
EWAS (birth EWAS: low = 662, increasing = 94, moderate/decreasing = 74; adolescent
EWAS: low = 720, increasing = 77, moderate = 64). However, group membership was
heavily skewed towards the low depression trajectory and therefore, our analyses might
not have been adequately powered. Issues of power likely contribute to EWAS
replication difficulties similar to those seen in GWAS.
There are also several limitations of our specific study in particular. First, we
were unable to control for antidepressant use in our study. Research has shown that
antidepressants may affect DNA methylation of certain sites in candidate genes such as
BDNF, SLC6A4, HTR1A and HTR1B (Serotonin receptor 5HT1A subtype variants),
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IL11 (interleuken-11), as well as more global whole genome changes (for recent
systematic review see Webb et al., 2020). It is possible that individuals in the increasing
group trajectory were more likely to use antidepressants throughout adolescence.
Therefore, DNA methylation differences found in the increasing symptom trajectory may
be confounded by anti-depressant effects on DNA methylation. Second, we measured
DNA methylation at age 15.5 and did not have DNA methylation data available at
baseline at age 12.5. This may be especially important for the increasing trajectory group,
where individuals were not experiencing clinical symptoms of depression at ages 12.5
and 13.5. Although it can be argued that we may be tapping into an epigenetic pathway
that has already been calibrated earlier on, we could not completely rule out issue of
reverse-causation. Third, depression is a heterogenous disorder that is often co-morbid
with other psychological disorders. Because we did not assess for co-morbidity, it is
unclear if our trajectory groups differed on prevalence of related psychopathology further
obscuring DNA methylation results. Future epigenetic research should focus less on
specific psychiatric diagnoses and instead emphasize broad trait-level vulnerabilities,
such as emotion dysregulation or impulsivity. Further discussion on clinical phenotypes
in behavioral epigenetic research is on page 81. Fourth, we did not control for the
presence of other biomedical disorders especially those related to inflammatory processes
including cancer, Type II diabetes, or cardiovascular disorder, though prevalence rates of
diseases associated with aging in adolescence is very low. Finally, due to issues of power,
we were not able to stratify our sample by gender though it was controlled for at every
level of analysis. Given the 2:1 depression gender ratio that emerges in adolescence and
the differential hormonal changes related to puberty for teenage girls, it is highly likely
that underlying epigenetic mechanisms for depression may be gender-specific, especially
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for those girls with increasing depression symptoms over time. The need for higherpowered gender specific EWAS for depression is compounded by the fact that our most
significant hit, that was also central to the cancer gene network, has been consistently
identified as a breast cancer tumor suppressor.
CHAPTER 9: Thesis Discussion
The Tissue Issue
One of the most salient debates in the viability of using DNA methylation to
understand complex psychological phenotypes is the “tissue issue.’ DNA methylation
profiles are tissue-specific, which means that each tissue (e.g. blood, brain, skin) has its
own unique DNA methylation profile as part of normative tissue differentiation. Since
most behavioral epigenetic studies utilize peripheral tissue, most commonly blood, a
major debate is whether peripheral tissue samples have utility for the study of disorders
that are thought to be primarily manifest in the brain. Simply put, does DNA methylation
that we observe in the blood, have anything to do with what is going on in the brain? One
study sought to characterize intra- and inter-individual methylome variation across whole
blood and multiple regions of the brain (Davies et al., 2012). They found that DNA
methylation at CpG island around promoter sites was largely conserved between blood
and brain regions, while CpG shores and intragenic regions showed tissue-specific DNA
methylation differences. Most strikingly, inter-individual DNA methylation differences
found in the blood were correlated (p < 0.001) with inter-individual differences in the
brain (correlation = 0.76 in the cerebellum and 0.66 in the cortex). This means that
differential DNA methylation patterns between two individuals that are detected in
peripheral blood are also present in the brain suggesting that peripheral tissues are still
relevant despite tissue-specific DNA methylation patterns. Similarly, another study found
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that interindividual variation in DNA methylation are highly correlated between whole
blood and brain when probes are in CpG promoter regions (Hannon et al., 2015).
However, they found that interindividual variation in DNA methylation between blood
and brain exists in 1-3% of 450k probes and warned against using blood DNA
methylation patterns as proxies for DNA methylation in the brain. It is important to note
that DNA methylation differences as assessed by candidate gene studies are often
substantiated with similar patterns in post-mortem brain samples, albeit not within the
same individual (e.g. Keller et al., 2010; Labonte et al., 2012; McGowan et al., 2009;
Stenz et al., 2015)
Although DNA methylation patterns in the blood may not always be aligned with
DNA methylation patterns in the brain, we argue that peripheral tissues can still provide
useful information about etiology of psychopathology. Peripheral tissue types may seem
irrelevant under the assumption that psychological disorders are primarily disorders of
the brain and are the result of dysfunction of neural circuitry. However, there has recently
been an explosion of research exploring the connection between the immune system,
chronic inflammation, and psychological disorders beyond depression (for various
reviews see Mitchell & Goldstein, 2014; Renna et al., 2018, 2018; Su, 2012; Monica
Uddin & Diwadkar, 2014). Similarly, a new research base focusing on the
gastrointestinal system has linked altered gut microbiome functioning to psychological
disorders as well (for reviews see Groen et al., 2018; Mayer & Hsiao, 2017; Nguyen et
al., 2018). Perhaps psychological disorders are caused by disruptions in multiple body
systems in addition to the brain and the traditional dichotomy between mind and body
should be reconceptualized when thinking about disease etiology. Peripheral tissue may
not be an exact proxy for brain processes but can instead be thought of as a window to
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disrupted pathways in other body systems that interact with, are a consequence to, or a
precursor to processes in the brain.
Furthermore, even if large scale access to post-mortem brain tissue was easier and
sample size was not an issue, there are other considerations to take into account about the
limitations of brain tissue sampling. First, one cannot rule out the profound effects that
death can have on DNA methylation patterns in the brain, especially if death was
traumatic or due to illness. Second, post-mortem samples will not tell us anything about
the etiology of psychological disorders and how they unfold over time during sensitive
periods of development. Third, if the hope is that DNA methylation will one day be a
biomarker for either the onset of psychological disorders or as evidence of wear and tear,
it must be easily and reliably accessed. It is likely that blood-based epigenetic studies will
continue, and emerging evidence suggests that limitations to this approach can be
surmountable, though confirmation in brain tissue remains important.
Effect Size
While epigenetic studies in cancer and other disorders typically manifest DNA
methylation differences of ~20% when comparing cases and controls, studies in
behavioral epigenetics examining psychological phenotypes often have effect sizes
ranging from 1-10% and sometimes even smaller differences are reported. Similarly, our
studies reported mean DNA methylation differences in the range of 1-2%. It has been
posited that large changes in DNA methylation as a result of stress would hinder any
possible social-emotional development in the same way that DNA methylation leading to
cancer renders the tissue completely lost of its normative function and as a result, large
effect sizes are not to be expected when assessing stress and psychopathology (Breton et
al., 2017).
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Furthermore, is important to note that there is usually a strong statistical
significance reported with these small differences, suggesting that even though the effects
are small, there is little variability in the measured values. An important example of this
is the robust literature linking maternal smoking during pregnancy and DNA methylation
in infant blood where effect sizes range from 1-13% (Breton et al., 2017). It is perhaps
also useful to recategorize what we see as small effects. Very small changes in DNA
methylation can have large effects on transcriptional activity. For example, one study
analyzing the DNA methylation of the imprinted insulin-like growth factor II (IGF2)
gene in umbilical cord blood, found that for every 1% difference observed in DNA
methylation, there was a doubling or halving of IGF2 transcription (Murphy et al., 2012).
Effect sizes are also isolated to DNA methylation differences in one CpG site and the
collective effect of multiple CpG sites on one gene or across many genes is largely
unmeasured (to our knowledge, there is no capacity to estimate regional effect sizes.
Though it is always imperative to question the clinical significance of effect sizes,
researchers must take into account the context in which they are being examined to truly
determine if they are relevant. The best way to assess the implications of a difference in
methylation is to further examine downstream processes such as level of gene expression;
though this was not available in the ALSPAC cohort.
Psychological Phenotypes in Behavioral Epigenetics
Difficulties with EWAS replication have historically been discussed in terms of
issues with power, technology, and statistical analysis. Less discussed is the likelihood
that the lack of replication and consequently, any meaningful biological understanding of
epigenetic pathways that underlie mental health disorders is due to the manner in which
psychological phenotypes are conceptualized in behavioral epigenetic studies.
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Psychological constructs are typically treated as categorical disease categories in the
same vein as biomedical disorders like cancer, but there is little evidence to suggest that
the actual underlying structure of psychological phenotypes matches that
conceptualization. In fact, this has been an important debate in the field of clinical
psychology where the current DSM-5 (Diagnostic and Statistical Manual of Mental
Disorders – 5) classification of psychological disorders in terms of a categorical disease
model has been vehemently criticized as ultimately failing to “carve nature at its joints”.
Extensive heterogeneity and comorbidity demonstrate that diagnoses are more like
heterogeneous constellations of features in multidimensional space within the context of
normative human experience and processes (Lilienfeld, 2014). Limiting samples to
individuals who only meet criteria for one particular psychological disorder or other ways
to methodologically obtain a “cleaner” experimental phenotype is not reflective of the
true nature of psychopathology where individuals often meet criteria for multiple
disorders at one time or have a lifetime history of multiple diagnoses. Our current
classification of psychological phenotypes may have utility in terms of reliable
identification and treatment, but it is severely limiting in its ability to study biological
pathology and etiology and should not be used as the default operationalization of
phenotypes in behavioral epigenetic studies. If psychological research in epigenetics is to
be elucidating and fruitful, as much care is to be taken in understanding and
conceptualizing the phenotype as has been taken to understand epigenetic methodology.
In these two studies we have attempted to remedy this somewhat by moving
beyond a case-control design. In study 1, we conceptualized psychopathology using
confirmatory factor analysis to extract conduct, hyperactivity, emotion problems factors
as well as a global psychopathology score. In study 2, we conceptualized depression
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using longitudinal trajectories that take into account change in symptoms over time.
There are many ways in which the psychological phenotype can be refined in future
studies for an increased possibility in finding underlying biological pathways. First, as we
attempted in our first study, psychological phenotypes can be broadened to get at more
meaningful underlying factors. Research in clinical psychology has found that the
structure of mental disorders can be potentially summarized by three core
psychopathological dimensions: internalizing (i.e. liability towards mood disorders like
depression and anxiety), externalizing (i.e. liability towards impulse and behavioral
control disorders like ADHD and substance use), and thought disorders (i.e. liability
towards disordered and disorganized thinking and symptoms of psychosis like
schizophrenia and bipolar disorder) (Caspi et al., 2014). In behavioral epigenetics,
psychological phenotypes may be expanded upon into these dimensions with the additive
bonus of increased sample size and statistical power.
Disorders can also be grouped in other meaningful ways, for example,
neurodevelopmental disorders such as autism, ADHD, and schizophrenia may have
similar underlying epigenetic mechanisms as research has already identified overlap in
genetic risk among these disorders (Owen et al., 2011). It would also be interesting to
examine DNA methylation variation on an even broader scale of those who have
psychopathology and those who have less or not at all. Researchers have posited some
evidence pointing to one general underlying dimension dubbed the “p factor” that
described an individual’s propensity to develop psychopathology period, where
individuals are classified on a low to high psychopathology dimension (Caspi et al.,
2014). It is plausible that epigenetic changes confer risk for psychopathology on a
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broader scale and lack of replicability may be due to the mistaken assumption that
different psychological disorders emerge from different epigenetic underpinnings.
On the other hand, psychological phenotypes could also be narrowed into
transdiagnostic endophenotypes that are “closer” to underlying epigenetic vulnerability in
the lengthy pathway between DNA methylation and complex behavioral and emotional
phenotypes. Endophenotypes can be described as constructs that provide the means for
identifying the downstream trait or facets of more complex observable behaviors as well
as the upstream consequences of genetic and epigenetic processes (Gottesman & Gould,
2003). Although endophenotypes have been more traditionally thought of as simpler
underlying biological processes (e.g. cortisol reactivity, sensory motor gazing, eyetracking, reward learning), that definition has been expanded to include transdiagnostic
personality traits that underpin psychopathology (e.g. neuroticism, impulsivity).
Endophenotypes are particularly useful due to the recurring nature of psychopathology in
a lifespan perspective as they are not state dependent and are more stably manifested in
the individual whether the psychological disorder is currently present or not (Gottesman
& Gould, 2003). The endophenotype concept fits within the Research Domain Criteria
(RDoC) framework, which was developed as an alternative to the DSM classification
system as a way to organize psychological disorders on transdiagnostic dimensional
domains (e.g. arousal and regulatory systems, cognitive processes) that focus on
pathophysiology across several units of analysis (e.g. genetics, physiology, behavior)
(Insel & Cuthbert, 2009). As discussed previously, studies examining prenatal stress,
DNA methylation, and infant neurobehavioral outcomes have utilized endophenotypes
such as cortisol reactivity (e.g. Houtepen et al., 2016; Oberlander et al., 2008; Tf et al.,
2008). There are a few studies who have also examined DNA methylation and its relation
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to cortisol reactivity later in development (Alexander et al., 2014, 2014; Ouellet-Morin et
al., 2013). For example, in one EWAS, researchers found that the methylation of one
locus in the Kit ligand gene (KITTLG) in adults mediated the relationship between
childhood trauma and cortisol stress reactivity (Houtepen et al., 2016). Although
endophenotype outcomes in behavioral epigenetic should also be expanded to include
other measures of cognitive, physiological, and biological functioning, it would also be
interesting for DNA methylation studies to examine transdiagnostic trait-like
endophenotypes such as neuroticism (i.e. the tendency to exhibit frequent and intense
negative emotions) or impulsivity instead of traditional disease model approaches.
Another consequence of overreliance on the disease model in studying
psychological phenotypes, is the lack of research on epigenetic pathways that promote
resilience as well as risk. It is likely that epigenetic mechanisms such as DNA
methylation play a major role not only in elucidating why some individuals go on to
develop psychopathology as a result of environmental stress but also why some do not.
Study 1 of this thesis is an attempt to begin to understand the biological underpinnings of
resilience to psychopathology in a sensitive period of development, but much more work
needs to be done in this area. Contrast to the thousands of EWAS and candidate gene
studies focusing on risk for negative outcomes, there is a lack of a substantial literature in
understanding the epigenetics of protective factors and resilience to psychopathology.
There have been a few studies examining the role of DNA methylation to resilience to
acute stress in animal models (Elliott et al., 2010; Taff et al., 2019; Uchida et al., 2011;
Wang et al., 2018), but very few exist in humans. There is some preliminary work
examining resilience to PTSD in combat soldiers. For example, one study found that in
soldiers with a diagnosis of PTSD, resilience, as measured by a range of coping
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strategies, was associated with DNA methylation age acceleration suggesting that aspects
of resilience may come at a biological cost (Mehta et al., 2018). To our knowledge, no
studies have examined epigenetic mechanisms of resilience to psychopathology in
childhood and much more work is needed to be done in this area. It would also be
interesting to examine how protective factors such as social support and maternal warmth
may alter epigenetic signaling pathways to promote resilience, especially early on in
development.
Future Research Directions
In addition to more refined clinical phenotypes as outcomes measures and a
greater focus of resilience and protective factors, more developmentally relevant
longitudinal designs are needed to push the field forward. However, this is easier said
than done as most longitudinal cohorts established decades ago could not have foreseen
the need for more frequent extractions of blood samples to assess temporal timing of
DNA methylation. Research utilizing longitudinal designs, including the ALSPAC cohort
in this thesis, is greatly limited by needing to make do with what existing data is
available. Future launches of longitudinal cohorts may have the benefit of establishing
designs and timing of assessments that may be more conducive to hypotheses of
underlying biological mechanisms. Studies with more frequent sampling of DNA
methylation across a period of time are greatly needed, not only to better establish
temporal order, but to gain better understanding the timing of epigenetic changes. How
quickly after stressors can DNA methylation changes be identified? Are they temporary
fluctuations or more permanent cellular reprogramming phenomena?
Additionally, innovated epigenetic designs beyond the traditional candidate gene
and EWAS case-control samples are necessary. Epigenetic research will be most robust
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when integrating multiple levels of analysis. The distance between DNA methylation and
a complex behavioral phenotype is vast and in between lies a number of cascading
processes. Future research should continue to include multi-omics measures including
genomics, transcriptomics, metabolomics, proteomics, and imaging data (Lin & Tsai,
2019). Furthermore, the polygenic risk score approach that has been utilized in
application of GWAS data should also be adapted to epigenetic research, given that
multiple CpG sites of multiple genomic regions are likely acting and interacting in
accordance with one another.
Finally, the interpretation of EWAS is often limited by how little is actually
known about the biological functioning of newly identified genes as much of what is
known about gene function is through cancer research. In theory, EWAS are hypothesis
generating analyses where novel genes implicated in psychological phenotypes are
discovered. However, there is very little if any follow-up (for example, candidate gene
analyses) on novel hits in the field of behavioral epigenetics. There are a large number of
novel genes in many EWAS that have not been more closesly examined. If the field is to
continue to grow, researchers must conduct more in-depth follow-up analyses on how
these genes are related to psychological phenotypes.
Clinical Implications
The seminal study conducted by Weaver and colleagues (2004), demonstrated in
an animal model that early life experience became embedded through DNA methylation
of the GR gene to propagate an anxious phenotype later in life. Perhaps the most striking
result of this study was that the epigenetic changes were reversible. Central infusion of a
histone deacetylase inhibitor into the brain effectively removed the methyl tags on the
GR gene and removed group differences in DNA methylation, GR transcription and
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expression, hypothalamic-pituitary adrenal (HPA) responses to stress, and most
importantly, the actual anxious phenotype. Previously anxious mice were now not
distinguishable from their non-anxious control counterparts. While epigenetic
pharmacotherapy is an exciting concept in treatment of mental illness, these results
demonstrate more of a proof of principle rather than possible reality in human
psychopathology. Current epigenome-editing technology uses DNA methyltransferase
(DNMT) inhibitors acting on DNA methylation and histone deacetylase (HDAC)
inhibitors targeting histone post-translational modification (i.e. another mechanism of
epigenetic mechanisms not discussed in this thesis) (Kular & Kular, 2018). However, in
humans these modifiers affect DNA methylation globally, exerting broad effects on the
epigenome, and current technology cannot target individual loci. And even if that
technology comes to fruition, it would be unclear which loci to safely target and in what
tissue without adverse pleiotropic side-effects. Unlike in cancers where malignant tumors
can be localized and targeted with global methylation changes, it remains to be seen how
this would be possible in complex psychological phenotypes that have social, emotional,
cognitive, and behavioral components.
Although direct biological intervention may not be possible, epigenetic research
has the potential to inform the classification and treatment of mental health disorders in
other ways. The most obvious utility is the central aim of this thesis: to better understand
the etiology and mechanisms of psychopathology. In addition, DNA methylation changes
can also serve as potential biomarkers that can predict and track clinical outcomes as well
as potentially classify particular subtypes of a disorder. For example, one longitudinal
study assessing postpartum depression identified 116 transcripts, related to estrogen
signaling, that were differentially expressed between cases and controls during the 3rd
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trimester that then predicted with 88% accuracy who went on to develop postpartum
depression in two separate sample cohorts (Mehta et al., 2014). Similarly, another study
posited the predictive utility of DNA methylation of HP1BP3 and TTC9B, both of which
are regulated by estrogen with 80% accuracy (Guintivano et al., 2014). Another study
using an epigenome-wide approach examined DNA methylation in the context of
treatment response to antidepressant medication. Results identified differential DNA
methylation in two genes, CHN2 and JAK2, that distinguished responders from nonresponders with CHN2 being replicated in an independent sample (Ju et al., 2019).
The future of behavioral epigenetics, aided by strides in technological advances,
improved bioinformatic methods, more meaningful and developmentally relevant
phenotypes, and innovative research designs, looks bright. However, the field is still in its
infancy and researchers must use caution in overinterpreting new discoveries. The more
that novel discoveries of the epigenome are uncovered, the more of our ignorance of the
complexities in relationships between genes and environments is revealed. It is unlikely
that epigenetics, like genetics before it, will be the final piece of the puzzle in solving the
disease burden of mental illness. However, it continues to hold enormous potential for
better understanding of the etiology of psychopathology and for better, more precise
treatment of it.
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APPENDIX: LIST OF TABLES
Table and Figures from Study 1: Variation in DNA Methylation of the Oxytocin
Receptor Gene Predicts Children's Resilience to Prenatal Stress (2017)

Figure 1. Flowchart of sample selection from ALSPAC cohort.
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Figure 2. Confirmatory factor analysis of Strengths and Weaknesses Questionnaire
(SDQ) subscales of conduct problems, hyperactivity, and emotional problems and global
problems.
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Figure 3. Linear Regression models used to classify resilient and non-resilient groups to global, conduct, hyperactivity, and
Table 1. Multiple Linear Regression Predicting Factor 1 Methylation and Individual Probes at Birth by Types of
Resilience
Global
Conduct
Hyperactivity
Emotional
Parameter
β
95% CI
β
95%
β
95% CI
β 95% CI
CI
Factor 1 Methylation
.220 .000.006.154
-.006.015 -.013.025
.323*
.031
.024
.013
*

Probe 1

.153

Probe 5

.274

Probe 10

.073

-.009.040
.004.041

.245*

-.012.021

*

.283*
.244

.003.051
.006.042
.002.035

.051

.022

.280

-.022.033
.005.042

.055

-.015.024

.042

*

.027

-.022.025
-.018.020
-.021.014

Note: β = Beta Weights; CI = Bootstrapped Confidence Intervals; Analyses controlled for sex and cell type
*
p < .05, **p < .01, ***p < .001.
emotional problems. Red (top half) dots represent the non-resilient group while the blue (bottom half) represent the resilient
group.
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Resilient
(N = 44)
Probes
Average
Probe 1
Probe 5
Probe 10

NonResilient
(N = 47)

%
2.2

M
.19

SD
.04

M
.17

SD
.06

2.5
2.3
1.7

.18
.14
.17

.05
.04
.04

.15
.12
.15

.04
.03
.02

Figure 4. This figure shows mean methylation percentages at each individual probe that makes up Factor 1 controlling for sex
and estimated cell–type composition. *p < .05, **p < .01, ***p < .001.
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Table 2. Descriptive Statistics of Resilient and Non-Resilient groups in Conduct Problems
Resilient
(N = 44)
N (%)
Gender
Male
Female

Environmental Risk
Prenatal
Ages 0-7
Ages 8-9

Psychopathology
Hyperactivity
Emotional Problems
Peer Problems
Prosocial Behavior
Social Cognition (Age 7)
Callous-Unemotional Traits (Age 13)
*
p < .05, Note: All psychopathology outcomes controlled for sex
*
p < .05, **p < .01, ***p < .001.

Non-Resilient
(N = 47)
N (%)

20 (46.5)
24 (50.0)

23 (53.5)
24 (50.0)

M (SD)

M (SD)

T-test

0.54 (0.46)
5.96 (4.46)
0.85 (1.81)

.047 (.429)
6.58 (5.80)
0.99 (1.76)

-0.750
0.564
0.387

M (SD)

M (SD)

F-test

-0.55 (1.10)
0.00 (0.67)
-0.10 (0.67)
0.61 (0.64)
2.24 (2.33)
1.79 (0.54)

0.45 (1.22)
0.31 (0.70)
0.17 (0.63)
-0.40 (1.03)
5.16 (3.65)
2.33 (0.61)

16.56***
4.90*
3.72t
31.18***
18.14***
16.87***
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Table 3. OXTR Single Nucleotide Polymorphism (SNP) effects on Probe 1 and Probe 10
SNP

SNP
chr

SNP pos

A1

A2

CpG site

CpG
chr

CpG pos

Beta

T-stat

Effec
t Size

Birth (Probe 1)

rs62243375

3

8810462

T

C

cg00078085

3

8810592

0.613

0.00

0.008

Birth (Probe 10)

rs237900

3

8808696

A

G

cg12695586

3

8810077

-0.328

0.00

0.004

Timepoint

Note: chr = chromosome, pos = position
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Table and Figures from Study 2: A Longitudinal Epigenome-wide Analysis of Depression Trajectories in Adolescence

Figure 5. Flowchart of sample selection from ALSPAC cohort
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Figure 6. Depression trajectories (measured with Short Moods and Feelings Questionnaire; SMFQ) obtained through latent
class growth curve modeling using the full ALSPAC sample (N = 8,360).
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Table 4. Descriptive Statistics for EWAS analyses at birth broken down by depression
trajectories.

Low

Increasing

Moderate/
Decreasing

Birth EWAS (N = 830)
N (%)
N (%) female

662 (80)
311 (47)

94 (11)
66 (70)

74 (9)
48 (65)

Birth covariates
Maternal smoking freq
1st trimester
2nd trimester
3rd trimester
Maternal marijuana freq
1st trimester
2nd trimester
3rd trimester
Maternal alcohol use freq
1st trimester
3rd trimester
Child gestation length (weeks)
Maternal age at birth (years)

M (SD)

M (SD)

M (SD)

Child birthweight (grams)
Adolescent Dep (age 12.5)
N (%) clin sig dep
Adolescent Dep (age 13.5)
N (%) clin sig dep
Adolescent Dep (age 16)
N (%) clin sig dep
Adolescent Dep (age 17.5)
N (%) clin sig dep

0.93 (3.46)
0.60 (2.69)
0.70 (2.98)

1.71 (5.04)
1.04 (3.65)
1.55 (4.75)

1.32 (4.49)
1.16 (3.87)
1.28 (4.69)

0.02 (0.19)
0.01 (0.16)
0.02 (0.22)a

0.05 (0.43)
0.05 (0.43)
0.10 (0.62)ab

0.01 (0.12)
0.03 (0.17)
0.03 (0.17)b

0.77 (0.81)
0.80 (0.79)
39.60 (1.48)
29.65 (4.27)
3509.50
(476.92)

0.84 (0.86)
0.79 (0.88)
39.33 (1.56)
29.49 (4.71)
3372.17
(480.59)

0.64 (0.69)
0.81 (0.81)
39.68 (1.45)
29.88 (5.17)
3472.26
(461.89)

2.94 (2.34)
2 (.03)
3.59 (2.93)
20 (3)
5.40 (3.22)
53 (8)
5.06 (3.85)
73 (11)

5.31 (2.56)
2 (2)
9.34 (5.19)
34 (36)
15.49 (5.78)
73 (78)
14.41 (5.11)
73 (78)

12.80 (3.64)
57 (77)
11.64 (4.53)
39 (53)
10.15 (5.72)
30 (41)
8.75 (4.66)
25 (34)

Note: M = Mean, SD = Standard Deviation; ANOVA with Tukey HSD was used to assess mean
differences in covariates, columns with different superscripts are significantly different from each
other; Dep = SMFQ Depression score; freq = frequency; clin sig dep = clinically significant
depression; Range of values for smoking, marijuana, and alcohol use are 0 (none) to 6 (frequent daily
use)
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Table 5. Descriptive Statistics for EWAS analyses at adolescence broken down by
depression trajectories.

Low

Increasing

Moderate/
Decreasing

Adolescent EWAS (N = 893)
N (%)
N (%) female
Adolescent Age
Adolescent Smoking
Adolescent Marijuana
Adolescent Dep (age 12.5)
N (%) clin sig dep (SMFQ > 11)
Adolescent Dep (age 13.5)
N (%) clin sig dep
Adolescent Dep (age 16)
N (%) clin sig dep
Adolescent Dep (age 17.5)
N (%) clin sig dep

720 (80)
346 (48)

77 (11)
54 (70)

96 (9)
61 (64)

M (SD)
17.14 (1.03)
0.85 (1.46)a
0.42 (0.97)a

M (SD)
17.15 (1.06)
1.68 (1.99)b
0.75 (1.37)ab

M (SD)
17.10 (1.08)
1.62 (1.80)b
0.93 (1.48)b

2.86 (2.30)
2 (.03)
3.53 (2.89)
20 (3)
5.35 (3.21)
43 (8)
4.99 (3.77)
72 (10)

5.27 (2.52)
2 (2)
9.49 (5.20)
32 (39)
14.88 (5.89)
53 (73)
14.83 (5.22)
58 (82)

12.69 (3.47)
56 (77)
11.73 (4.56)
39 (53)
9.87 (5.39)
21 (39)
8.93 (4.79)
35 (36)

Note: M = Mean, SD = Standard Deviation; ANOVA with Tukey HSD was used to assess mean
differences in covariates, columns with different superscripts are significantly different from each
other; Dep = SMFQ Depression score; freq = frequency; clin sig dep = clinically significant
depression; Range of values for smoking and marijuana are 0 (none) to 6 (frequent daily use)
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Table 6. EWAS comparing increasing (N = 94) to low (N = 662) groups using DNA methylation obtained at birth
Location
M
Meth
Adj
M (SD)
CpG
Gene Chr
Position
details
b (SE)
p
q
(SD)
diff
R
increasing
low
Island, -2.12e5’ UTR,
02
7.44e0.965
0.952
cg08214693 SCRIB 8 144885540 promoter (3.80e0.074 0.025
1.3%
06
(0.018)
(0.049)
03)
Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj =
Adjusted; M = mean; SD = standard deviation.
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Figure 7. Manhattan plot of EWAS comparing increasing (N = 94) to low (N = 662) groups using DNA methylation obtained
at birth. Red line represents FDR significance.
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Table 7. EWAS comparing combined high (N = 173) to low (N = 720) groups using DNA methylation obtained at
adolescence
Location
M
Meth
Adj
M (SD)
CpG
Gene Chr
Position
Details b (SE)
p
q
(SD)
diff
R
increasing
low

cg06758781 AACS

12

125570653

South
Shore;
Body

-1.23e02
(2.21e03)

3.53e08

0.015

0.021

0.136
(0.048)

0.156
(0.042)

2%

Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj = Adjusted; M
= mean; SD = standard deviation; Location details = location in genomic space, location on the gene, and whether
CpG is near the promoter region
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Figure 8. Manhattan plot of EWAS comparing combined high (N = 173) to low (N = 720) groups using DNA methylation
obtained at adolescence. Red line represents FDR significance.
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Table 8. EWAS comparing increasing (N = 96) to low (N = 720) groups using DNA methylation obtained at
adolescence
Location
Adj M(SD) M(SD) Meth
CpG
Gene
Chr
b (SE)
p
q
Details
R
low
inc
dff
cg06460328 CBFA2T3 chr16 North
-2.64e-02
7.17e- 0.030 0.296 0.136
0.156
2%
Shelf;
(4.85e-03)
08
(0.048) (0.042)
5’UTR; hhhhhhhh
Body
cg15414828 LRTOMT/ chr11 Island;
-1.36e-02
NUMA1
5’UTR, (2.62e-03)
1st exon;
promoter

2.77e- 0.059 0.061 0.080
0.090
07
(0.021) (0.021)

1%

cg00624332

LDB1

chr10 Island;
-1.48e-02
TSS200; (2.94e-03)
promoter

6.75e- 0.060 0.046 0.062
0.074
1.2%
07
(0.023) (0.027)

cg14558639

USF2

chr19 Island;
-2.58e-02
Body;
(5.16e-03)
promoter

7.18e- 0.060 0.052 0.080
0.100
2%
07
(0.040) (0.044)

cg05901451

HEY2

chr6

Island;
5’UTR,
1st exon

-2.97e-02
(5.95e-03)

7.79e- 0.060 0.062 0.224
0.242
1.8%
07
(0.048) (0.049)

cg18786593

--

chr2

South
Shore

-0.020
(4.14e-03)

9.61e- 0.060 0.078 0.096
0.106
1%
07
(0.034) (0.034)

103

cg21772776

BLCAP

chr20 Island;
-2.87e-02
9.81e- 0.060 0.075 0.138
0.163
2.5%
5’UTR, (5.80e-03)
07
(0.047) (0.042)
1st exon;
promoter
Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj =
Adjusted; M = mean; SD = standard deviation; inc = increasing; Meth diff = percentage methylation
difference. Location details = location in genomic space, location on the gene, and whether CpG is near the
promoter region
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Figure 9. Manhattan plot of EWAS comparing increasing (N = 96) to low (N = 720) groups using DNA methylation obtained
at adolescence. Red line represents FDR significance.
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Table 9. Regional analyses comparing combined high (N = 173) to low (N = 720) groups using DNA
methylation obtained at adolescence
DMR position (hg19)
Number of probes in the
DMR p-value
Gene
DMR
Chr3:1273478764
0.000
SNORA33, SNORA81,
127347978
SNORD66, SNORD2,
SNORD5, SNORD63,
SNORD61, SNORA24,
SNORA18
Note: DMR. = differentially methylated region
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Table 10. Regional analyses comparing increasing (N = 96) to low (N = 720) groups using DNA
methylation obtained at adolescence
DMR position (hg19)
Number of probes in the
DMR p-value
Gene
DMR
Chr3:1273478764
0.000
SNORA33, SNORA81,
127347978
SNORD66, SNORD2,
SNORD5, SNORD63,
SNORD61, SNORA24,
SNORA18
Chr11:130184046130184122

2

0.000

ZBTB44

Chr20:3615592536156146

6

0.000

BLCAP

Note: DMR. = differentially methylated region
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Figure 10. GeneMANIA gene network analysis using significant and nominal hits from increasing versus low groups EWAS
using DNA methylation in adolescence. Striped black circles represent genes associated with the probes found to be related to
depression trajectories in the EWAS. Solid black circles represent additional genes predicted by GeneMANIA based on genetic
and physical interactions, shared pathways and protein domains as well as protein co-expression data.
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Table 11. Gene ontology analyses from GeneMANIA gene network analysis using significant and
nominal hits from increasing versus low groups EWAS using DNA methylation in adolescence.
Function
FDR
Coverage
sequence-specific DNA binding
1.60e-8
10/255
bHLH transcription factor binding
2.79e-7
5/18
cardiac septum morphogenesis
0.000002
5/27
cardiac septum development
0.000007
5/37
cardiac ventricle development
0.00005
5/56
cardiac chamber morphogenesis
0.00006
5/60
muscle structure development
0.00009
7/244
cardiac chamber development
0.00009
5/70
regulatory region DNA binding
0.0001
7/268
transcription regulatory region DNA binding
0.0001
7/267
regulatory region nucleic acid binding
0.0001
7/268
RNA polymerase II transcription factor binding
0.0001
5/74
sequence-specific DNA binding RNA polymerase
0.0004
6/200
II transcription factor activity
cardiac right ventricle morphogenesis
0.0004
3/10
cardiac ventricle morphogenesis
0.0006
4/47
heart morphogenesis
0.0007
5/120
histone deacetylase binding
0.0007
4/51
chordate embryonic development
0.0007
5/125
embryo development ending in birth or egg
0.0007
5/125
hatching
aorta morphogenesis
0.0008
3/14
ventricular septum morphogenesis
0.0008
3/14
aorta development
0.0009
3/15
embryonic organ development
0.001
5/144`
transcription factor complex
0.002
5/155
mesenchymal cell differentiation
0.002
4/68
smooth muscle cell differentiation
0.002
3/19
ventricular septum development
0.002
3/21
mesenchyme development
0.003
4/80
regulation of neuron differentiation
0.004
5/188
E-box binding
0.004
3/27
heart development
0.005
5/203
artery morphogenesis
0.006
3/30
RNA polymerase II activating transcription factor
0.007
3/32
binding
outflow tract morphogenesis
0.007
3/33
artery development
0.007
3/33
regulation of neurogenesis
0.007
5/228
regulation of nervous system development
0.01
5/256
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regulation of binding
0.01
4/127
regulation of DNA binding
0.02
3/46
in utero embryonic development
0.02
3/47
activating transcription factor binding
0.02
3/48
muscle cell differentiation
0.02
4/151
mesenchymal cell development
0.03
3/60
negative regulation of binding
0.04
3/61
blood vessel morphogenesis
0.04
4/170
regulation of vasculogenesis
0.04
2/10
stem cell differentiation
0.04
4/171
cardiocyte differentiation
0.04
3/64
cardiac epithelial to mesenchymal transition
0.05
2/12
endocardial cushion morphogenesis
0.05
2/12
cardiac left ventricle morphogenesis
0.05
2/12
protein heterodimerization activity
0.05
4/191
blood vessel development
0.05
4/193
Note: Coverage = how many genes in this network/how many genes identified in this process
overall in the literature
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Figure 11. GeneMANIA gene network analysis using significant and nominal hits from increasing versus low groups EWAS
using DNA methylation in adolescence with the addition of AACS from high versus low groups EWAS. Striped black circles
represent genes associated with the probes found to be related to depression trajectories in the EWAS. Solid black circles
represent additional genes predicted by GeneMANIA based on genetic and physical interactions, shared pathways and protein
domains as well as protein co-expression data.

Supplementary Section
SI 1. Factor analysis procedure for reducing OXTR methylation data and results obtained from Cecil and colleagues (2014)
for study 1.
Procedure:
We used exploratory factor analysis (EFA) to examine associations between the 12 OXTR probes at birth. EFA is a data
reduction technique that groups correlated probes into a smaller set of factors which account for shared variance between them
– an advantageous method when the pattern of relationships between variables (i.e. probes) is not known. The optimal number
of factors was determined by comparing fit statistics between models estimating 1 to 5 factors. Model fit was first established
using the chi-square statistic, which tests the difference between observed and expected covariance matrices, producing a nonsignificant value if this difference is close to zero . In the event of a significant chi-square value, we examined additional
relative fit indices , including the mean square error of approximation (RMSEA; acceptable fit =< .08), the Comparative Fit
Index and Tucker-Lewis Index (CFI & TLI; acceptable fit => .90). As a next step, confirmatory factor analysis (CFA) was run
to validate the factor structure identified by the EFA. Once methylation factors at birth were confirmed, we tested whether they
remained consistent from birth onwards (i.e. birth vs age 7; age 7 vs age 9), by examining correlations between probes in each
factor, and mean levels of DNA methylation in probes within each factor.
Results:
Correlations between the 12 OXTR probes at birth can be found in SI3. Using EFA, we identified 3 methylation factors at birth
(containing 3 probes each), which showed the best model fit: X2 (33) = 41.15, p = .16. We then used CFA to validate the 3factor model and extract factor scores (i.e. containing shared variance between probes in each factor). Model fit was
satisfactory (X2 (24) = 70.03 p <.01; CFI = .91; TLI = .86; RMSEA = .08, 90% CIs = .06, .10). See SI4 for probe descriptive
statistics, standardized loadings and factor correlations. Probe correlations for each factor remained consistent between birth
and age 7, as well as between age 7 and age 9, but mean levels varied across time (see SI5). We present findings relating to
Factor 2 as it associated with both the environment and CU. Of note, all probes included in this factor were physically located
on the same Exon (i.e., 2) of OXTR . Details pertaining to Factor 1 and Factor 3 are available upon request.
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SI 2. Confirmatory Factor Model of OXTR methylation patterns at birth obtained from Cecil and colleagues (2014) for Study 1
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SI 3. Intercorrelations between environmental risk domains across developmental periods and confirmatory factor models
obtained from Cecil and colleagues (2014) for Study 1
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SI 4. QQ-plot for EWAS comparing increasing (N = 94) to low (N = 662) groups using DNA methylation obtained at birth
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SI 5. Q-Q plot for EWAS comparing combined high (N = 173) to low (N = 720) groups using DNA methylation obtained at
adolescence
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SI 6. Q-Q plot for EWAS comparing increasing (N = 96) to low (N = 720) groups using DNA methylation obtained at
adolescence.
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